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ABSTRACT
The purpose of this retrospective case-control study was to assess risk factors
contributing to hospital acquired methicillin Staphylococcus aureus (HA-MRSA) and
gain a better understanding of the burden of HA-MRSA infection in patients with spinal
cord injuries. The study was also conducted to see if new information would be found on
HA-MRSA infections and validate or refute current research for patients in a dedicated
spinal cord injury unit at a Veterans Affairs Medical Center. During the study period, the
infection control department identified 95 cases of HA-MRSA. Additional data
retrospectively collected were basic demographics, admitting diagnosis, presence of
varying comorbidities, ASIA score, presence of indwelling medical device, BMI, LOS,
MRSA colonization, and quarterly hand hygiene compliance. The patient population was
described using appropriate univariate descriptive statistics and crude odd ratios (ORs)
with 95% confidence intervals (CIs) calculated. The most common sources of infection
for cases were ulcer related (31.6%), from skin and soft tissue infections besides pressure
ulcers (23.2%), 14.7% were Foley catheter related, 8.4% were blood stream infections
and 22.1% were from other sites/sources.

EPIDEMIOLOGY of HA-MRSA
Assessment of risk factors for HA-MRSA for spinal cord injury patients in this study
found that colonization (OR: 3), device use (Foley OR: 3.3, PICC OR: 39.4, use of both
OR: 21.1) , paralysis (1.9), ASIA score A (OR: 4.5), amputee (OR: 3.5), decubitus ulcer
(OR: 7.1), length of hospital stay > 30 days (OR: 17.1) and a hand hygiene compliance
</= .89 (OR:1.88) were each significantly associated with acquiring a HA-MRSA
infection. The significant risk factors were found to be similar to those described in
previous studies supporting the need for the MRSA bundle currently in place. The study
also affirmed that this population has special medical needs and that hand hygiene
compliance is correlated with infection and transmission of MRSA. This information will
aid in strengthening the design of the infection control program currently in place.
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EPIDEMIOLOGY of HA-MRSA
CHAPTER 1
PURPOSE and SIGNIFICANCE
Introduction
Understanding the burden of healthcare-associated methicillin-resistant Staphylococcus
aureus (HA-MRSA) in both healthcare and community settings is imperative for designing
effective prevention programs and for the reduction of HA-MRSA infections (Centers for
Disease Control and Prevention (CDC), 2011). Affecting certain populations disproportionately,
such as individuals with low socioeconomic status and injection drug users; healthcareassociated infections are among one of the top ten leading causes of preventable deaths within
hospitals in the United States. Hospitals acquired infections (HAIs) result in increased morbidity
and mortality and are also responsible for a substantial increase in healthcare costs each year
(Klevens, Morrison, Nadle, Petit & Gershman et al., 2007). Because of the increased costs, and
morbidity and mortality related to HAIs, the reduction of HA-MRSA has been a top priority in
the United States for major stakeholders in the public health, the medical, and infection
prevention communities (Agency for Healthcare Research & Quality (AHRQ), 2009; Centers for
Medicare & Medicaid, 2009; CDC, 2007; The Institute for Healthcare Improvement, (IHI) 2006;
Platt, 2011; Association for Professionals in Infection Control and Epidemiology, (APIC) 2009).
Several of the major stakeholders include the CDC, APIC, the Institute of Medicine (IOM), and
the AHRQ. Considered an emerging issue and a threat to public health, Healthy People 2020
created a new goal, “...Prevent, reduce, and ultimately eliminate healthcare-associated infections
(HAIs) (US Department of Health and Human Services, 2010). Reflecting the commitment to
reducing healthcare-associated infections, two supporting objectives were created by Healthy
People 2020: (HAI-1) reduce healthcare-associated infections by reducing central line associated
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bloodstream infections; and (HAI-2) to reduce invasive healthcare-associated methicillinresistant Staphylococcus aureus infections by 75% nationwide (US Department of Health and
Human Services, 2010).
Another initiative to reduce HAIs and led by the World Health Organization (WHO) is part of
the First Global Patient Safety Challenge. This program was launched in 2005 and in 2009 added
additional goals and programs with an emphasis on hand hygiene. These programs were
developed to support healthcare workers and improve hand hygiene compliance and thus support
the prevention of often life threatening HAI (WHO), 2009).
In the last two decades MRSA has become the most commonly identified multi-drug
resistant pathogen in the United States causing invasive infections and a fifth of the hospital
acquired infections often resulting in longer hospital stays, increased morbidity and mortality and
increased costs (Cosgrove, Yi, Kaye et al., 2005; Fairclough, 2008; Gould, 2006; Reed,
Friedman, Engemann et al., 2005; Shorr, 2007; Shorr, Tabak, Gupta et al., 2006). Invasive
infections caused by MRSA also result in poorer outcomes, increased recovery time, and higher
re-infection rates than non-invasive infections (Boucher & Corey, 2008; Chambers, 2005;
Cosgrove, 2005; Klevens, Edwards, & Gaynes, 2008; Liebowitz, 2009; Sakoulas, Perencevich,
Schwaber, Karchemer, & Caremeli, 2003).
Purpose of Study
Over the past 20 years, the incidence of infections caused by antimicrobial-resistant
pathogens has increased dramatically, especially in vulnerable high-risk populations, such as
those patients in the intensive care unit (ICU) and those who are immunocompromised and
debilitated (Croft, Mejia, Barker, Maxwell & Dart, et al., 2009; Sarikonda, Micek, Doherty,
Reichley & Warren et al., 2010; Weber, Huang, Oriola, Huskins & Noskin et al., 2007). The
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CDC has estimated a direct medical cost per patient of MRSA to be $27,083 to $34,900,
assuming 120,000 MRSA infections per year, (Rojas & Liu, 2005) and with an estimated annual
direct hospital cost of MRSA for the United States of $3.2 billion to $4.2 billion (American
Health and Drug Benefits (AHDB), 2009). This burden to the healthcare system does not take
into account the indirect costs of MRSA to the patient and society, lost income and lost
productivity (AHBD, 2009). In addition to the aforementioned costs, excess costs that are often
associated with resistant pathogens may also be due to the necessity to use more expensive
antibiotics, central venous access for prolonged infusion, additional laboratory monitoring,
diagnostic testing and contact isolation for the patient (Shorr, 2007 ; Gould, 2010). This leads to
substantial medical costs and also an increased use of medical and personnel resources.
Healthcare-associated infections, or HAIs, have become the most common complication of
hospital care according to the CDC (CDC, 2007; Scott, 2009). Nearly 2 million patients suffer
from infections annually with deaths resulting from HAI’s estimated to be 99,000 and health care
costs often exceeding $28 to $33 billion annually (CDC, 2007 & Scott, 2009). Such infections
were long accepted by clinicians as an inevitable hazard of hospitalization; however, recent
efforts have demonstrated that by understanding the burden of MRSA in specific populations and
hospital settings, implementing relatively simple measures such as hand hygiene, a majority of
such infections can be prevented (Berwick, Calkins, McCannon & Hackbarth, 2006; Institute for
Healthcare Improvement, 2006; McCannon, Schall, Calkins & Nazem, 2006; Weber, SickbertBennett, Brown & Rutala, 2007). As a result of these efforts and with present evidence showing
healthcare-associated infections are preventable, hospitals and providers are under intense
pressure to reduce the transmission and burden of these infections. Given the intense pressure
upon hospitals to reduce HA-MRSA, predictors and risk factors for transmission and acquisition
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of HA-MRSA have been addressed by a number of studies in hospital and community settings.
Some of the predictors and risk factors addressed in these studies include such factors as MRSA
colonization, previous hospitalization, and length of hospital stay (Croft et al., 2009; Klevens,
Edwards, & Gaynes, 2008; Murthy & Frick, 2011; Ruhe et al., 2010; Santos, Machado, Camey,
Kuchenbecker & Barth, 2010). Additional studies focused on other possible risk factors and
predictors associated with MRSA, such as hemodialysis, malnutrition and trauma (Kaye et al.,
2011).These risk factors have been used for surveillance purposes to target patient populations in
different settings who may need specific interventions to prevent acquisition and transmission of
HA-MRSA. Other variables that have been explored to be possible predictors and risk factors for
infection and transmission of MRSA include invasive devices, age, chronic conditions such as
hepatitis and HIV, and stays in long term care facilities (Evans, Hershow, Chin, Foulis & Burns
et al., 2009; Garshick, Kelley, Cohen, Garrison, & Tun et al., 2005; Klevens, Edwards, &
Gaynes, 2008). Comorbidities associated with MRSA infections and of interest because of an
aging population include diabetes, decreased functional status and obesity (Chen et al., 2010;
Eseonu, Middleton & Eseonu, 2011; Wang et al., 2010).
These infections are especially common in the intensive care unit (ICU) and acute care
setting, therefore, recent studies have focused on preventing HAIs in these particular areas
(Fortaleza, Melo, & Fortaleza, 2009; Kappel, Widmer, Geng, Arx & Frei et al., 2008; Rosenthal,
Kyeremanteng, Hooper & Shojania, 2008; Scchweickert, Geffers, Farragher, Gastmeier, &
Behnke et al., 2010). Because information is scarce and research has focused on preventing HAIs
in these settings, a clear understanding of risk factors and predictors of MRSA transmission and
acquisition is needed when attempting to translate this practice to patients with spinal cord
injuries (Garcia, Moreno, Garrote & Cercenado, 2010; Kappel, Widmer, Geng, Arx & Frei et al.,
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2008).
Patients with spinal cord injuries are a unique population requiring long-term specialized
care. Many of these patients suffer from chronic pain resulting in depression, anxiety, anger and
substance abuse. Physical impairment from spinal cord injuries often cause chronic urinary tract
infections, pressure ulcers, amputation, pneumonia, infections, pulmonary emboli and
development of co-morbidities such as diabetes and cardiovascular disease, each impacting the
patient’s engagement with treatment and motivation to recover and stay healthy. Therefore,
understanding disease and infectious processes following this type of injury is necessary for
customizing the appropriate treatment strategy as well as customizing infection control strategies
for this population of patients (Evans et al., 2009). Addressing similarities and differences
amongst different patient populations will also allow better patient care and improve patient
safety.
Significance of the Study
Healthcare – associated infections with MRSA have been an increasing concern in acute care
Veterans Affairs (VA) Medical Centers. Previous efforts to reduce MRSA transmission and
acquisition have been attempted with varying degrees of success; however, in 2007 an MRSA
“bundle” was implemented in acute care VA hospitals nationwide in an effort to further decrease
healthcare – associated infections and transmission of MRSA. In 2008, this same “bundle”
approach was implemented within the VA in the spinal cord injury unit (SCIU). The bundle
consisted of universal nasal surveillance for MRSA, contact precautions for patients colonized or
infected with MRSA, hand hygiene, and a change in the institutional culture whereby infection
control would become the responsibility of everyone who has contact with patients.
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Past research suggests that infection and transmission rates have been reduced following
implementation of preventive measures (APIC, 2007; Berwick, Calkins, McCannon &
Hackbarth, 2006; CDC, 2007; Institute for Healthcare Improvement, 2006; McCannon, Schall,
Calkins & Nazem, 2006) making this study important for several reasons. First, understanding
the burden of HA-MRSA in patients with spinal cord injuries is important to this medical center
in order to design an effective infection program tailored to the specific needs of this population
to help prevent the transmission of MRSA and reduce HA-MRSA infections. Second,
researchers have studied the transmission and acquisition of MRSA in similar populations and
settings generalizing their results; however, what remains to be fully explored is how these risk
factors and predictors affect patients in a spinal cord injury unit where information is scarce. And
third, this research will provide new information on the topic of MRSA and validate previous
studies that have assessed risk factors and predictors for acquiring an MRSA infection within the
hospital environment.
LITERATURE REVIEW
Brief History of MRSA
Prior to the advent of antibiotics, Staphylococcus aureus (S. aureus) emerged as a bacterial
pathogen that was capable of causing a variety of significant human diseases leading to a high
fatality rate (Gordon & Lowy, 2008; Chambers, 2005). Sir Alexander Fleming discovered
penicillin in the early 1900s however it was not until the 1940s that penicillin was introduced
into clinical care increasing survival rates for people with Staphylococcal disease and other
bacterial pathogens. Shortly after the introduction of penicillin into clinical use, Kirby published
a report in 1944 describing penicillinase-producing strains of S. aureus from hospital patients
(Chambers, 2001 & Kirby, 1944).
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Following World War II, penicillin became more readily available and used with increasing
frequency within hospitals yielding a greater prevalence of penicillinase-producing strains of
S. aureus. Within a few years most hospital strains of S. aureus were resistant to penicillin
(Chambers, 2001). Penicillinase is an enzyme S. aureus is capable of producing which has the
ability to interfere with the beta-lactam ring on penicillin. This renders it ineffective against
Staphylococci and produces resistance (Barber, 1961; Diagnostic Microbiology, 2011). By the
early 1950s most hospital strains of S. aureus were beta-lactamase producing or resistant yet
penicillin continued to be the drug of choice and recommended in the medical community
throughout the 1970s as an effective antimicrobial against Staphylococcal disease (Chambers,
2001). As these penicillin resistant strains emerged in the hospital setting -HA-MRSA,
community strains of S. aureus continued to be sensitive to penicillin until the late 1990s.
Following the emergence of penicillin resistant strains of S. aureus in hospital settings,
additional beta-lactam antimicrobials, or synthetic penicillins, were developed for the treatment
of penicillin resistant S. aureus and included cloxacillin, methicillin, and nafcillin. The
effectiveness of these antimicrobials was short lived - due to selective pressure of antibiotic
exposure (Chambers, 2001) and by 1961 physicians in the United Kingdom reported seeing
resistant strains to penicillin, streptomycin, tetracycline (Jevons, 1961), and methicillin (Barber,
1961). These particular bacteria resistant to beta-lactam antimicrobials were later classified as
methicillin-resistant Staphylococcus aureus (MRSA) (Emmanuel, 2008; Heymann, 2008) and
were first reported among patients in the United States in 1968 at Boston Hospital (Barrett,
McGhee, & Finland, 1968).
Four decades later and after the first reports of MRSA at Boston Hospital, MRSA is now a
major public health problem causing recurrent infections and serious sequelae in even the
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healthiest of individuals. MRSA is a very difficult pathogen to treat and is consistently reported
in hospitals and communities in the United States with an increasing prevalence worldwide
causing substantial morbidity, mortality, and cost (Boucher & Corey, 2008; Chambers, 2001;
Derenski, 2005; Diekema & Climo, 2008; Payman & Thierry, 2008).
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Table 1. Timeline of Staphylococcus aureus Infection and Resistance
Year

Event

1940

Penicillin introduced

1942

Penicillin-resistant Staphylococcus aureus appears

1959

Methicillin introduced; most S aureus strains in both hospital and community
settings are penicillin resistant

1961

Methicillin-resistant S. aureus appears

1963

First hospital outbreak of methicillin-resistant S. aureus (MRSA)

1968

First MRSA strain in U.S. hospitals

1970s

Clonal spread of MRSA globally, very high MRSA rates in Europe

1982

4% MRSA rate in the United States

1980s, early 1990s

Dramatic decreases in MRSA rates due to search-and- destroy; By 1999, <1%
MRSA rate in the Netherlands; that rate has been sustained to date despite
increasing MRSA rates in other parts of the world

1996

Vancomycin-resistant S.aureus (VRSA) reported in Japan

1997

Approximately 25% MRSA rate in US hospitals; vancomycin use increases;
Serious community-acquired MRSA (CA-MRSA) infections reported; Pediatric
deaths reported

2002

First clinical infection with VRSA in the United States

2003

MRSA rates continue to increase; approx. 60% MRSA rate in intensive care
units; outbreaks of CAMRSA reported in numerous community settings and
also implicated in hospital outbreaks; 2006 >50% of staphylococcal skin
infections seen in emergency departments caused by CA-MRSA; HA-MRSA
rate continues to increase; Distinction between HA-MRSA and CA-MRSA on
epidemiological basis becomes increasingly difficult

2007

Report of active, population-based surveillance for invasive MRSA done in
2004-2005 estimates 95,000 invasive MRSA infections and 19,000 deaths from
MRSA per year; Continued reports in the medical literature and media about
severe CA-MRSA infections; Several states pass or are considering legislation
regarding control of MRSA and public reporting of MRSA rates ; Strategies to
control MRSA, including public reporting of MRSA infections, are hotly
debated; “staph” and MRSA become household words

Mayo Clinic Proceedings, 2007
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Community Acquired Methicillin-Resistant Staphylococcus aureus
In the last 10 years, MRSA has not only become a hospital pathogen, but also a community
pathogen. CA-MRSA differs from HA-MRSA in that the infections may involve younger and
healthier individuals without any known risk factors for infection or colonization (Boucher &
Corey, 2008; CDC, 1999; Chambers, 2005; Kuehnert et al., 2005; Lui et al., 2008; Skov et al.,
2005).
Gaining national attention, the first cases of community-acquired MRSA infections where no
known risk factors could be found were first reported in the United States in the late 1990s.
These cases were among four young children under the age of 5 in Minnesota and North Dakota,
each case was fatal (Centers for Disease Control and Prevention, (CDC), 1999; Herold et al.,
1998; Adcock et al., 1998). These children did not have any established risk factors such as
recent hospitalization, prolonged antibiotic therapy or a relative working in a health-care setting.
Subsequently these cases were treated with a beta-lactam antibiotic, cephalosporin, known to be
an effective antibiotic for the treatment of S. aureus at the time. Laboratory reports confirmed
MRSA, causing a delay in the use of appropriate antibiotic therapy and possibly contributing to
the fatal outcomes of the children.
These cases represented a paradigm shift in the epidemiology of MRSA. Additional outbreaks
followed these reported cases in other community settings and among diverse populations whom
appeared to be at risk for infection but with no known risk factors. Reported infections initially
involved skin and soft-tissue and were among prison inmates, injection drug users, men who
have sex with men (MSM), military personnel, athletes, the medically underserved, and also
children attending child-care facilities (Boucher & Corey, 2008; Gordon & Lowy, 2008; Klevens
et al., 2006; Miller & Diep, 2008). Later, necrotizing pneumonia, fasciitis and sepsis were
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reported as a result of CA-MRSA causing serious infections and fatalities (Francis et al., 2005);
Miller et al., 2005; Mongkolrattanothai, Kahana, & Daum, 2003).
CA-MRSA has the ability to spread within households due to close confinement of family
members. Those colonized with CA-MRSA often will experience repeated infections with CAMRSA representing 15%-74% of skin and soft tissue infections presenting to the U.S.
emergency departments and most often seen in healthy children and young adults (Mileno, 2008;
Orlovic & Smego, 2009).
Colonization
Risk factors associated with MRSA colonization are well documented and include prolonged
antibiotic exposure, previous or recent hospital admission or nursing home admission, recent
outpatient visits, chronic illness, injection drug use or direct contact with an MRSA-colonized
patient, healthcare worker or family member (Beam & Buckley, 2006; Chambers, 2001; Klevens
et al., 2006; Orlovic & Smego, 2009).
Colonization for individuals with MRSA may be persistent or transient for months, with most
patients remaining asymptomatic (Beam & Buckley, 2008; Sanford, Widmer, Bale, Jones &
Wenzel, 1994). Colonization most often occurs within the nares or nostrils, as well as other body
sites such as the axillae, groin, perineum and gastrointestinal tract (Gordon & Lowy, 2008).
These bacteria do not pose a threat unless the integrity of the skin is breached, with a break in the
skin, whether by shaving, surgery, aspiration, or through the insertion of a central line or
catheter. Humans and animals are both natural reservoirs for MRSA (Chambers, 2001) with
transmission of MRSA primarily through direct person to person contact; however, there are
documented cases of animal to human and human to animal transmission ( Juhasz et al., 2007;
van Loo et al., 2007; Weese et al., 2005).
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In 2004 a survey from the National Health and Nutrition Examination Survey (NHANES)
estimated that greater than 4 million individuals in the United States or approximately 1.5% of
U.S. residents are colonized with MRSA in the anterior nares (Gorwitz, 2008). Recently
published studies have arrived at varying conclusions regarding colonization of MRSA and the
association with MRSA infections.
Safdar and Bradley (2008) performed a systematic review and found in their study on
patients with MRSA nasal colonization that the incidence and risk for subsequent infections with
invasive MRSA is up to four times higher among carriers, particularly for patients in the
Intensive Care Unit (ICU). Research by Croft et al. (2010) reported in their study that MRSA
colonization was a predictor of subsequent infection among trauma patients and similarly,
Schweitzer et al. (2008) found that previous MRSA colonization or infection was predictive of
subsequent MRSA blood stream infections (BSIs). Datta & Huang (2008) studied the risk of
infections and death due to MRSA in long-term carriers and found that individuals who are
known to have “harbored MRSA for >1 year are at high risk for subsequent MRSA morbidity
and mortality” (pg. 176). Accounting for 39% of the infections included pneumonia, soft tissue
(14%), and central venous catheter infection (14%).
In 2003, Huang and Platt studied 209 adult patients colonized with MRSA and following
review of infection-control records found that after discharge from the hospital, 29% developed
infections over the next 18 months. The infections identified were bacteremia, pneumonia, soft
tissue infection, and osteomyelitis. Eighty percent of the study patients with previous MRSA
infection developed an MRSA infection in a new site with 49% developing an infection after
hospital discharge. By contrast, Sarikonda et al. (2010) found that MRSA nasal colonization in
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patients admitted to the ICU was a poor predictor for subsequent occurrence of MRSA lower
respiratory tract infections and BSI. Klevens et al. (2006) reported identical findings.
Colonization and infection rates vary by setting such as the type of health-care facility,
geographic location, and the population being studied (Davis, Stewart, Crouch, Florez &
Hospenthal, 2004). Understanding prevalence of infection and colonization within one’s own
health-care facility is important for identifying high risk populations and for customizing
successful infection control programs necessary to prevent acquisition and transmission of
MRSA to patients, employees, and family members.
Transmission
Transmission of MRSA from environmental sources and hands is well documented in the
literature. Microorganisms have the ability to live on human hands 2-60 minutes following
contact with patients and/or a contaminated environment (WHO, 2009). Another portal of entry
for bacteria is during the performance of high-risk patient care procedures such as surgery or the
insertion of a central line. Each of these actions may contribute to the risk of HAIs and
colonization.
Hospitals have long been known to harbor MRSA on fomites such as stethoscopes, bedside
tables, pagers, charts, and beds (Huang, Mehta, Weed, & Price, 2006; Kassem, Sigler, & Esseili,
2007; Miller & Diep, 2008). Computer keyboards are also known reservoirs for contamination
with MRSA not only in the hospital setting but also occurring in the community setting. In a
pilot study examining the survival time of MRSA on hospital surfaces, Huang, Mehta, Weed, &
Savor (2006) reported that MRSA has the ability to live on charts, bedside tabletops, and cloth
curtains for 9-12 days. Any of these reservoirs can be sources for person to person transmission
of MRSA resulting in infection and colonization.
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Previous research provides substantiated evidence on the various ways transmission of MRSA
may occur within the hospital environment. Therefore, the VAMC is following guidelines
provided by the CDC to reduce such transmissions and understands the importance in using
certain evidence based practice interventions.
MRSA Bundle
The Veterans Affair Medical Center implemented an “MRSA Bundle” consisting of universal
nasal surveillance for MRSA, contact precautions for patients who are either colonized or
infected with MRSA, a greater emphasis on hand hygiene compliance, and a change in employee
behavior and organizational culture towards hospital acquired infections.
A bundle is characterized by the Institute for Healthcare Improvement (IHI) as a structured
way of improving processes used for improving health outcomes based on evidence-based
practices (Institute for Healthcare Improvement (IHI), 2006a). The VAMC implemented the
MRSA bundle as a targeted infection control strategy to reduce methicillin-resistant S. aureus
transmission and infection. Recent data supports the use of “bundles” of interventions to achieve
successful reduction in MRSA transmission and infections (IHI, 2006b; Resar et al., 2005;
Youngquist et al., 2007).
Prior to full implementation of the MRSA bundle, the VAMC introduced the concepts of the
MRSA bundle to HCWs through the use of education, games, and contests. The VAMC also
conducted focus groups to involve staff and determine how to implement the initiative using
their ideas. Once full use of the MRSA bundle began, the MRSA coordinators collected the
swabbing data and surveillance which was reported back monthly to the leadership. There were
MRSA champions on each nursing unit to help move the initiative forward and disseminate
information.
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During the implementation of the MRSA Initiative, the infection control program also placed
an emphasis on hand hygiene. In addition to the interventions of the National VA Initiative, all
clinical personnel were involved in a collaborative, intensive, and self-monitoring of hand
hygiene compliance. Each clinical unit had a hand hygiene champion trained by the Infection
Control Department to observe and report quarterly. Non-staff volunteers were enlisted, trained
by Infection Control staff, and often deployed on nights or weekends as independent observers of
hand hygiene compliance. Patients and visitors were engaged in hand hygiene education and
encouraged to practice hygiene.
Continuous improvement of these interventions is consistently being made within the VAMC
to aid in the reduction of MRSA HAIs and colonization of patients during their hospital stay. The
CDC recommends a bundle approach for the reduction of infections caused by multi-drug
resistant organisms. For this strategy to be successful, it is important for the infection control
department to have an understanding of their patient population, risk factors and prevalence of
MRSA. This understanding will provide information to be used for educational purposes and
improved infection control strategies.
Contact Precautions
Controlling the spread of MRSA within the hospital often requires a multi-modal
approach. Literature suggests that quality improvement for the reduction of MRSA
transmission and infection cannot be achieved by using a single intervention; therefore, a
combination of improvement strategies is the approach many hospitals are using, to include
contact precautions (Boyce, 2001).
The CDC recommends contact precautions when the facility deems MRSA to be of special
clinical and epidemiologic significance. Following these recommendations, when single-patient
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rooms are available, the VAMC will assign priority for these rooms to patients with known or
suspected MRSA colonization or infection with highest priority given to those patients who have
conditions that may facilitate transmission or infection, such as uncontained secretions or
excretions. When single-patient rooms are not available, the VAMC will cohort patients with the
same MRSA in the same room or patient-care area. When cohorting or grouping patients with
the same MRSA is not possible, the VAMC will place MRSA patients in rooms with patients
who are at low risk for acquisition of MRSA and associated adverse outcomes from infection
and those who are likely to have short lengths of stay.
The CDC recommends healthcare workers wear gloves whenever touching the patient's
intact skin or surfaces and articles in close proximity to the patient (e.g., medical equipment, bed
rails). In addition to gloves, a gown is to be worn upon entry into the room and removed prior to
leaving the room. Hand washing should then be performed before leaving the patient-care
environment and upon leaving ensure that clothing and skin do not contact potentially
contaminated environmental surfaces. This could result in possible transfer of microorganisms
to other patients or environmental surfaces after leaving the room.
Contact precautions are used to reduce the risk of transmission of pathogens to the healthcare
worker or conversely; to reduce the chance of the healthcare worker serving as a vector for
transmission to patients. Contact precautions require patient cohorting or single-bed rooms for
patients, and wearing gloves and gown simultaneously prior to contact with a patient. These
guidelines are used by many hospitals and recommended by the CDC.
Hand Hygiene
Semmelweis’ hypothesis in 1846 that the hands of healthcare personnel were the vector for
spreading illness to some patients was initially rejected. However, hand hygiene is now widely
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accepted today and is integral to the prevention of health care associated infections. Multidrug
resistant organisms (MDROs) are transmitted by healthcare workers due to inadequate hand
hygiene, poor technique, or contamination of the environment, equipment or supplies (Allegranzi
& Pittet, 2009). Transmission sometimes results in health-care associated infections that cause
approximately 80,000 deaths annually and significantly increase morbidity, mortality, and costs.
Many hospitals currently use core prevention strategies developed by the CDC when
implementing clinical guidelines used to improve patient safety. In 2007 the Department of
Veterans Affairs instituted a directive implementing the National VA MRSA Initiative which
outlined a bundle methodology to decrease the rates of MRSA hospital-acquired infection.
During the implementation of the MRSA initiative, the infection control department placed an
emphasis on hand hygiene.
In 2001, Stone posited “that the treatment effect is so great that if hand hygiene were a new
drug it would be used by all” (pg. 280). During patient care, healthcare worker's hands become
progressively colonized with commensal flora as well as pathogens while interacting with
patients (Pittet et al., 1999; WHO, 2009). In the event of ineffective hand hygiene, the longer the
duration of care, the higher the degree of hand contamination. Healthcare workers are often busy
and may not wash their hands for a sufficient amount of time or not use an adequate amount of
antibacterial solution leading to poor hand decontamination. When infection control strategies
break down during the care of a single patient and/or between patients’ contact, microbial
transfer is likely to occur.
Contamination of healthcare worker’s hands has been associated with numerous hospital
acquired outbreaks of multi-drug resistant organisms due to cross transmission to patients and
also to the environment (Sartor et al., 2000; Shafie, Alishaq, & Garcia, 2004). Performing
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proper hand hygiene during patient care is the most effective way and the simplest means in
reducing and preventing HAIs. However, despite this simple measure, hand hygiene compliance
among healthcare workers, especially physicians, remains suboptimal (Squires et al., 2013;
Pincock, Bernstein, Warthman, & Holst, 2012). A number of studies have shown that HCWs
compliance with hand hygiene is less than 50% and that of physicians often lower (Squires et al.,
2013). Due to the complexities within the healthcare environment, hand hygiene compliance is
often a difficult behavior to change and maintain over time.
Literature has documented a number of factors contributing to healthcare workers adopting
hand hygiene or resisting change; however, barriers specific to physicians are not as well
described. In a cross-sectional survey of physicians by Pittet and colleagues (2004), adherence
for physicians showed an average of approximately 57% hand hygiene compliance, higher than
the 50% norm but varied across medical specialties. Reasons for adherence to hand washing at
the individual level was associated with an awareness of being observed, the belief of being a
role model for others, a positive attitude toward hand hygiene after patient contact, and easy
accessibility to hand –rub solution. However, a limitation to this study was the direct observation
of the physician washing their hands and this may have influenced the increased compliance.
Pittet and colleagues (2004) found perceived environmental barriers for non-adherence for
physicians to include high workload activities associated with high risk for cross-transmission.
Additionally, certain medical specialties such as anesthesiology, emergency medicine and
surgery were shown to have lower compliance rates due to time constraints and complexities in
performing the job. Additional studies have shown a myriad of environmental barriers related to
non-adherence to hand hygiene compliance for nurses and other HCWs to include lack of access
to sinks, difficulty locating products, empty dispensers, and also time constraints (Boyle et al.,
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2001; Squires et al., 2013).
On the individual or personal level, barriers described as risk factors for non-adherence
included attitudinal beliefs, and skin irritation from repeated hand washing (Boyle et al., 2001;
Squires et al., 2013). Another study focusing on nurses at the individual level and using a
behavioral approach was described by Boscart and colleagues (2012) which identified
motivational sources such as a person’s personal safety and their families’ safety to yield greater
hand hygiene compliance. Additional motivational factors described in the study as important to
nurses was to have individual feedback and self-monitoring to increase awareness and leading to
greater compliance.
Good hand hygiene has for many years been considered the most important and cost effective
means to help prevent the spread of HAIs, yet maintaining compliance over 50% continues to
remain challenging for most hospital infection control departments.
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Figure 1:
5 Moments for Hand Hygiene (2009).

Figure 1: World Health Organizations’ (WHOs’) 5 Moments for Hand Hygiene (2009).
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MRSA Active Surveillance
Active MRSA surveillance in the hospital setting may be helpful in the identification of
patients at risk for developing MRSA infections; that is, screening all patients on admission for
MRSA colonization to identify which patients need to be placed in contact precautions to reduce
the spread to healthcare workers, patients, and family members (Bruce et al., 2010; Jain et al.,
2011). Hospitals nationwide are facing declining reimbursement for HAIs and although MRSA
surveillance is costly, studies show that successful programs can pay for themselves by reducing
a patient’s stay in the hospital. HAIs can double the length of stay for patients depending on
complications and the facility (McCune, 2012).
Much attention has been focused on multi-drug resistant organism at the national and state
levels and via public media. Some policy makers are calling for universal screening in hospitals
to reduce HA-MRSA by identifying those colonized upon admission to the hospital or prior to a
surgical procedure in hopes of reducing infection (Weber et al., 2007). Universal screening using
a rapid Polymerase Chain Reaction (PCR) method for MRSA is expensive and remains
controversial due to the variability in reducing HA-MRSA in the healthcare community (Murthy
et al., 2010; Harbarth et al., 2008; Jeyaratnam et al., 2008; Keshtgar et al., 2008; Hardy et al.,
2010; Robicsek et al., 2008).
Harbarth et al. (2008) conducted a prospective interventional cohort study at a Swiss teaching
hospital using a rapid screening method for patients at admission in combination with
conventional infection control measures compared to a control group using only standard
infection control measures. This study showed no reduction in MRSA HAIs when using
universal screening in combination with contact precautions in surgical patients. Another study,
randomized and with high baseline MRSA infection rates by Jeyaratnam et al. (2008) also failed
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to show a reduction in HA- MRSA infection rates. The investigators used a similar rapid
molecular technique versus the conventional culture method.
Conversely, Robicsek et al. (2008) conducted an observational study in a 3-hospital, 850-bed
organization with approximately 40,000 annual admissions comparing rates of MRSA during
and after hospital admission in three consecutive time periods. After a baseline year, all patients
admitted to the ICU were screened for MRSA colonization using PCR for twelve months and
followed by screening for all hospital admissions. Patients testing positive for MRSA were
placed in contact precautions. After three years, the prevalence density of aggregate hospitalassociated MRSA disease per 10,000 patient-days at baseline and during ICU surveillance was
8.9, 7.4 the second year and 3.9 after the third year. The result of this intervention was associated
with a large reduction in MRSA infection during admission and thirty days after discharge.
Keshtgar and colleagues (2008) conducted a study targeting surgical patients using PCR
testing prior to undergoing emergency and elective surgery in a teaching hospital. MRSA
positive patients were started on suppression therapy of mupirocin nasal ointment and undiluted
chlorhexidine gluconate body wash. Comparing means to the previous year, MRSA bacteraemia
fell by 38.5% and MRSA wound isolates fell by 12.7%. The reduction in MRSA infection was
possibly related to the quick turnaround time for reporting of MRSA and the ability to administer
the appropriate surgical prophylaxis prior to surgery.
Huang et al. (2011) in an effort to control MRSA spread in a neonatal intensive care unit
(NICU) implemented several infection control measures. These included enhanced hand hygiene,
alcohol-based handrubs, active MRSA surveillance, and contact precautions. This resulted in a
significant decrease in all types of MRSA infections and colonization, especially blood stream
infections.
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Using a rapid molecular testing method for identification of patients colonized with MRSA
upon admission is highly debated despite the quick turn-around time for the result. Using PCR is
expensive, and results can vary depending on the facility, and adoption of the proposed method.
Policymakers have tried to mandate the testing method, but with literature showing varying
results in the value of the test and the reduction of HAIs, hospitals continue to have an option as
to whether to continue to use conventional culture methods.
Culture Change
Another component of the MRSA bundle is the incorporation of institutional culture change
throughout the hospital which integrates communication, teamwork, and leadership so that
infection control and patient safety becomes the responsibility of everyone involved in the care
of patients. This is to ensure that all persons within the facility take part in infection control and
prevention practices reflecting the needs and desires of patients, whether this is through teaching
and education, or through practice.
A result of the culture change is that everyone is responsible for infection control and
prevention practices not just the department of hospital infection control and epidemiology. This
additional component of the bundle can aid in the decrease in transmission of MRSA and a
decrease in the MRSA bioburden in the environment within the healthcare facility.
Risk Factors for MRSA Infections
Age
Numerous factors predispose patients to MRSA and most studies have shown a strong
association with age and infection. Kuehnert et al. (2005), using discharge data, reported MRSA
rates for septicemia, pneumonia, and other infections increase with patient’s age with most
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diagnoses occurring in persons > 65 years of age. In the same study, patients <14 and 15-44
years of age had higher MRSA hospitalization rates when compared with patients age 45-64
and > 65 years of age. Overall, the MRSA rate increased with patient age. Klevens et al. (2008)
also found an increase in MRSA infections among older adults aged > 65 years and in hospitals
with < 200 beds. Blood stream infections increased significantly from 27.0% in the period 19901994 to 54.1% during the time period of 2000-2004. Among children during these same time
periods aged 0-18 years, the proportion of infections due to antimicrobial resistant organisms did
not change.
Fridkin et al. (2005) found that children less than two years of age were significantly more
likely to be diagnosed with CA-MRSA infections when compared to children of differing ages.
Another study, by Payman & Delorme, (2008) in a medical center also reported a significant
increase in the incidence of MRSA among young patients 6-25 years of age, as well as patients
45-50, and the elderly, 86-90. No differences were found in males or females.
A study by Liu et al. (2008) found among San Francisco residents, persons aged 35-44 years
of age and 45-54 years of age and older adults >85 years of age were at the greatest risk of
infection caused by community onset of MRSA and with an annual incidence of hospital-onset
MRSA infection to increase with age, especially the elderly. Men were 2.4 and 1.7 times more
likely to have community-onset and hospital-onset MRSA than women, respectively. Again,
combined hospital-onset and community-onset MRSA was three times higher in persons who
were black versus white.
Numerous factors predispose patients to MRSA infections and most studies have shown a
strong association with age and infection. Literature suggests those at highest risk include the
young and the elderly with the chance of infection increasing as age increases.
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Comorbidities and MRSA
Fridkin et al. (2005) identified underlying chronic conditions which increase a patient’s
contact with healthcare workers and length of stay within the hospital as predisposing factors for
either colonization or infection with MRSA disease. The chronic conditions identified by Fridkin
include diabetes, cardiovascular disease (CVD), smoking, HIV infection, and alcohol abuse.
Yates et al. (2009) concluded in their study that wound chronicity, inpatient care, and chronic
kidney disease each independently predisposed patients to MRSA infection. Malani, et al. (2008)
also found diabetes to be associated with higher MRSA infections as well as chronic pulmonary
disease, and hypertension.
Many patients with spinal cord injuries have poor functional status. In a nested case-control
study in patients 65 and older, researchers found that a high Charlson comorbidity score,
immobility, and wound class each were independent predictors of MRSA surgical site infections.
Kaye et al. (2011) studied predictors for bloodstream infections in a retrospective case-control
study on patients age 65 and older and found such comorbidity factors as obesity, presence of a
central line on admission, and urinary incontinence to be predictive of an MRSA infection.
A prospective cohort study on patients admitted to an intensive care unit (ICU) and staying
for a minimum of two days were studied for HA-MRSA. Variables excluded from the study were
those that could be assessed within 24 hours of admission to the ICU because HA- MRSA
infection is usually determined after 48 hours. Four variables found to be risk factors for MRSA
infections in the ICU are intubation, open wound, antibiotic treatment, and steroid
administration. These findings do not contradict other studies; however, intubation as a risk
factor has not been fully explored (Yamakawa et al., 2011).
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Wang and colleagues (2010) conducted a large one year prospective study in a tertiary care
center in Taiwan differentiating between HA-MRSA and CA-MRSA using molecular typing to
identify predictors of infection. Using univariate analysis, age, ICU onset, length of stay before
index culture, diabetes mellitus, bedridden status, recent surgery, and catheter-related infection
were associated with HA-MRSA. Community onset (CA-MRSA) was isolated from soft tissue
infections and deep-seated infection, and not related to a surgical procedure. The study used
patients with positive blood cultures, or bacteremia.
Comorbidities can play a central role in the acquisition of a hospital acquired infection
resulting in longer hospital stays, increased cost to the patient and often debilitating effects, if not
death. Older adults are at higher risk because of the presence of multiple comorbid conditions,
functional impairment and a reduced immune response.
Invasive Devices
Invasive devices pose the greatest threat to patients for serious infections. The presence of an
indwelling central venous catheter is the single strongest predictor of a bloodstream infection
(Kaye et al., 2011), mechanical ventilators may cause serious respiratory infections and urinary
catheters can result in catheter-associated urinary tract infections. 40% of the 2 million hospital
associated infections reported each year are urinary tract infections and 80% of the infections are
due to the presence of indwelling urinary catheters (Chen et al., 2013).
A retrospective case-control study was conducted by Kaye et al. (2011) to examine predictors
of nosocomial bloodstream infections in older adults. In this study, of the 830 cases, 81% of the
hospital-acquired blood stream infections were catheter related with 23% infected with MRSA,
and MRSA was the most common pathogen isolated. Independent predictors of the catheter
related blood stream infection (CRBSI) were male sex, obesity, the presence of a central line, a
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gastrostomy tube, and urinary incontinence at the time of admission. The presence of the central
line on admissions almost doubled the risk factor for a blood stream infection while the
gastrostomy tube was associated with almost three times the risk. An unusual finding included an
association with being male as an increased risk for infection however the reason for this was
unclear and not discussed.
A prevalence study was conducted in patients with and without spinal cord injury to
investigate the risk of hospital acquired infection by Girard, Mazoyer, Plauchu, & Rode (2006).
The prevalence of infection was higher in the spinal cord injury group than in those without
injury, 23.4% and 4.8% respectively, with most infections classified as urinary tract infection.
Urinary catheterization is very common and significantly more frequent in spinal cord injury
patients than non-spinal injury. The spinal cord injury group had a greater number of
comorbidities; however, the only independent predictor of infection was having an indwelling
urinary catheter. Other common infections found in this group included skin and soft tissue,
often related to decubitus ulcers.
A retrospective case-control study by Yoon et al. (2010) from January 2006 to February
2009 looked at predictors of persistent methicillin-resistant S. aureus bacteremia. In this casecontrol study the researchers found independent factors associated with MRSA bacteremia to be
long term use of medical devices, such as central lines, MRSA infection in more than one site,
and long term vancomycin treatment.
Another problem with indwelling devices is the chance for the patient to become colonized
with a multiple drug resistant organism, such as MRSA. Considered high risk for infection,
Mody et al. (2007) studied the relationship between the use of indwelling devices and
colonization in patients from a nursing home facility. Of the 100 patients in the device group, 55
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were colonized with MRSA at various sites, compared with 23 in the control group. Literature
has shown an association with colonization as a risk factor and predictor for subsequent MRSA
infection.
Patients considered high risk, such as those with a spinal cord injury, may develop serious
infections due to the use of indwelling devices. Many patients with spinal cord injuries use
intermittent catheterization or have an indwelling urinary catheter, require central line placement
for treatment due to infection, or require mechanical ventilation. The most effective way to
prevent infections related to devices is to reduce the incidence of use, ensure the device is
clinically indicated and use evidence based guidelines for insertion.
Hospital Length of Stay
Patients who remain in hospitals for extended lengths of time are exposed to longer
antimicrobial use, invasive procedures and greater contact with healthcare workers. Past studies
have suggested that each of these characteristics increases a patient’s chance to acquire MRSA;
therefore, length of stay is a possible risk factor (Santos et al., 2010; WHO, 2009). Barnett and
colleagues (2009) studied the effect of MRSA infection on the length of stay in an intensive care
unit and found that patients with MRSA infections had a relative risk of discharge when
compared to staying that was approximately 20% lower than that for patients without MRSA.
Contributing factors for the additional stay was found to be attributed to how ill the patient was,
the number of comorbidities present, and if the infections were occurring early during their stay
in the ICU. Prolonged stays in the ICU not only impacted the risk of infection but was shown to
be associated with a slight risk in mortality.
Another study associated with poor outcomes related to MRSA and hospital length of study
was conducted by Eseonu, Middleton, & Eseonu (2011). The study was conducted in a major
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orthopedic trauma center in surgical patients over an 11 year study period. Length of stay for
patients admitted was found to be significantly associated with an adverse outcome when the
LOS was greater than 30 days. 62% of these patients suffered an adverse outcome compared to
24% that did not. Other studies have suggested a higher incidence of post-operative infections in
males, yet this study with 38% of the cohort being male and 62% female, found no association
between gender and outcomes. The mean age within the group with a good outcome was 71,
while the mean age of the adverse outcome group was 69; this is contrary to the findings in
previous work. Patients with diabetes and the site of the infection were not found to have a
significant association with a poor outcome either.
Looking at trends in hospitalizations with antibiotic-resistant infections in the US, 19972006, Mainous et al. (2011) used national hospital discharge data to study the length of stay for
infection related hospitalizations. From 1999-2000 the length of stay rose at first and then began
a decline from 1997-2006, totaling an overall 40% decline with a median stay of 6.62 and 3.97
days, respectively. The study’s results also suggested that length of stay in the hospital was
closely related to the presence of health insurance. As the proportion of patients without
insurance with infection-related hospitalizations with antibiotic resistance increased, the length
of stay for those patients without insurance decreased, showing a median length of stay of 4.15
days. Patients with health insurance during the 10-year period had a median length of stay of
5.49 days; therefore suggesting the mean length of stay was shorter for patients without health
insurance.
Patients who remain in hospitals for extended lengths of time are exposed to longer
antimicrobial use, invasive procedures, greater contact with healthcare workers and the hospital
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environment. Each of these factors may contribute to a patient acquiring a hospital related
infection increasing a patient’s morbidity and mortality.
Quality Improvement and Patient Safety Movement
Over the last ten years patient safety has become a top priority in hospitals, emphasizing the
importance of effective surveillance and prevention activities performed by infection control
programs. In the mid 1800s, Florence Nightingale emerged as the first infection prevention and
control champion in the healthcare industry. Nightingale believed in preventive medicine
resulting in the creation of standardized methods for cleaning hospitals. Around the same time,
Dr. Ignaz Semmelweis discovered that simple hand washing could prevent the spread of bacteria
from patient to patient, reducing infections and amputations, as well as deaths. Semmelweis'
colleague, Oliver Wendell Holmes also made a similar discovery yet both physicians were
criticized by their peers regarding their findings due to skepticism. Another milestone in
reducing infections involved the surgeon, Joseph Lister, publishing ground breaking work on
antisepsis and is credited as being the first person to use a sterilization process in the operating
room and therefore reducing the spread of infection amongst patients (Smith, Watkins, &
Hewlett, 2012).
In the 1960s, hospital surveillance began due in large to the emergence of S. aureus in
hospitals. Surveillance has since evolved as an important component of infection control
programs used for identifying the sources causing hospital outbreaks, identification of problem
areas in the hospital environment, and for setting priorities for infection control activities.
Surveillance data is also used to provide feedback to staff and physicians regarding infection
rates and trends and can lead to action for reduction of hospital acquired infections.
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In the 1970s, the National Nosocomial Infection Surveillance (NNIS) was created for the
purpose of collecting, analyzing, and disseminating data on HAIs and to standardize definitions
for infections. The SENIC project, which was a Study on the Efficacy of Nosocomial Infection
Control, published in 1974, found that one third of HAIs could be prevented by effective
infection control programs and by the 1990's, the Healthcare Infection Control Practices
Advisory Committee (HICPAC) was formed by the CDC. This committee has been instrumental
in establishing standardized guidelines used by infection control programs throughout U.S.
hospitals resulting in improved quality processes and a reduction in HAIs.
In 1999, the Institute of Medicine published Today's Patient Safety and Quality Initiatives
which reported on adverse events in hospitals, deaths, and the costs related to these adverse
events. Recommendations resulting from this report included a proposal for hospital infection
control programs to establish Patient Safety programs making the job of reducing HAIs and
providing a safe work environment for all employees a top priority. A number of organizations
are involved in the Patient Safety movement such as the Joint Commission on Accreditation of
Healthcare Organizations and the Institute of Medicine. National Patient Safety Goals were
developed by the Joint Commission and currently must be followed for hospital accreditation.
Several examples of the goals infection control are responsible for overseeing include the
monitoring of hand hygiene practices, development of methods for prevention of catheter related
bloodstreams infections and eventually mandatory reporting of HAIs. A recent quality initiative
developed by the Institute for Healthcare Improvement (IHI) is the "bundle." This type of
measure is used by the VAMC for the reduction of MRSA HAIs. The bundle consists of
improved hand hygiene, contact isolation, universal surveillance, and culture change within the
hospital setting.
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Improving the quality of patient care through surveillance and prevention activities is a
valuable asset provided by infection control programs. Over the last ten years a greater emphasis
has been placed on reducing such adverse events as HAIs caused by MRSA. Proposed guidelines
can aid infection control programs in reducing infections, deaths, and the cost related to each of
these.
Summary
Prior to 1970, infections resulting from MRSA were uncommon in hospital settings. By the
1980s and 1990s reports of HA-MRSA steadily increased, and by 1998 CA-MRSA was first
reported among young children with no known risk factors (Mileno, 2008). Over the past 20
years, the incidence of infections caused by antimicrobial-resistant pathogens has increased
dramatically, especially in vulnerable high-risk populations, such as those patients in the
intensive care unit (ICU) and those who are immunocompromised and debilitated (Croft et al.,
2009; Sarikonda et al., 2010; Weber et al., 2007). The CDC has estimated a direct medical cost
per patient of MRSA to be $27,083 to $34,900. Assuming 120,000 MRSA infections per year,
(Rojas & Liu, 2005) there is an estimated annual direct hospital cost of MRSA for the United
States of $3.2 billion to $4.2 billion (American Health and Drug Benefits, 2009).
Because of the increased costs, and increased morbidity and mortality, the reduction of HAMRSA has been a top priority in the United States for major stakeholders in the public health,
medical, and infection prevention communities (Agency for Healthcare Research & Quality,
2009; Centers for Medicare & Medicaid, 2009; CDC, 2007; The Institute for Healthcare
Improvement, (IHI) 2006; Platt, 2011; Association for Professionals in Infection Control and
Epidemiology, 2009). As a result of these efforts by major stakeholders and with present
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evidence showing healthcare-associated infections are preventable, hospitals and providers are
under intense pressure to reduce the transmission and burden of these infections.
Individual interventions, such as universal surveillance or greater compliance with hand
hygiene are unlikely to work alone as effective measures in reducing MRSA transmission and
acquisition. Reduction in the number of HAIs and transmission of MRSA within the hospital
setting requires a comprehensive approach for successful outcomes and sustainability, and for
establishing guidelines and criteria for hospital infection control and quality improvement.
Use of Theory
The theories used in this study include the Theory of Reasoned Action (TRA) and the Theory
of Planned Behavior (TPB), frequently referred to as TRA/TPB. To provide specificity and to
show the strength of the theory, each theory is discussed in detail with definitions of the
constructs and examples related to infection control practice. The study was informed by theory
for the development of research questions related to hospital acquired infections.
A theory that has received considerable attention in regards to health behavior change and
proposes that the most important determinant of a person’s behavior is a person’s intent, is the
Theory of Reasoned Action by M. Fishbein (Fishbein, 1967). This theory was designed to study
volitional behaviors or those behaviors that are performed at will (Luszczynska & Sutton, 2005).
Along with Fishbein, Icek Ajzen proposed four constructs within this theory which helped them
to develop the conceptual framework. These constructs include: intention, belief, behavior and
attitude. Behavioral intention is defined by Fishbein and Ajzen as, “an indication of a person’s
readiness to perform a behavior and it is considered an immediate antecedent of
behavior”(Ajzen, 2006). Behavioral belief is a person’s intent to perform a behavior and the
consequence that is related to performing the behavior and their subjective norms (social
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pressures) associated with the behavior. Attitude toward the behavior is “the degree to which
performance of the behavior is positive or negatively valued,” (Ajzen, 2006). This is determined
by a group of accessible behavioral beliefs linking the behavior to various outcomes. In the
context of infection control practices, if a healthcare worker feels a strong commitment toward
good patient care and to reduce infections through proper hand hygiene compliance, as a result,
this person will have a positive attitude towards this task each time it needs to be performed. The
opposite is true as well, negative beliefs about infection control practices, such as the need to
wash hands repetitively and causing an irritation to the HCWs hands or a lack of understanding
of the risk of infection, might yield low hand washing compliance.
Subjective norm “is the perceived social pressure to engage or not engage in a behavior”
(Ajzen, 2006). A few examples of the type of social pressure a healthcare worker may
experience which influences the behavior are social networks within the hospital and include
peers, co-workers, physicians, or infection control managers. Therefore, if a person is concerned
about what other people may think or are concerned about another person’s perception of their
job performance, this may provide motivation for a person to follow recommended guidelines for
hand washing, and for insertion, cleaning, and maintenance of devices. This is a positive
subjective norm and the person believes they are performing the appropriate behavior. The
opposite of this thought process is true as well. An example of a positive subjective norm related
to infection control practice may include healthcare workers who view co-workers or physicians
as important people in their lives. They also believe these people, through observation, approve
of their actions and participation in following appropriate infection control practices such as
hand washing compliance. Each of the examples described above are behaviors that are purely
volitional and may predict behavioral intention and the actual behavior.
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In 1991 Ajzen expanded the Theory of Reasoned Action by adding an additional construct
related to self-efficacy, perceived behavioral control, to create the Theory of Planned Behavior.
These are not two different theories, rather a modification of the Theory of Reasoned Action
reflecting those behaviors that are not fully under volitional control, or behaviors not performed
at will. This modification reflects upon the perception by the healthcare worker as to whether or
not an action, or job is within reason or difficult to perform. A person’s behavior is strongly
influenced by their confidence (self-efficacy) and their ability to perform a behavior. A
healthcare worker may view a task as difficult and these difficulties are perceived as barriers
when performing some infection control practices, such as hand washing. The reasons for these
perceptions may include the thought of repetitive hand washing as very time consuming and
taking away from other important patient care duties, or a lack of resources to perform the job.
These theories inform the research to understand the behaviors of healthcare workers towards
infection control measures, such as compliance with hand hygiene recommendations to aid in the
reduction of HAIs (McLaws, Mahariouei, & Askarian, 2012; Pittet, 2004; O’Boyle, Henly &
Larson, 2001).
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Figure 2.
TRA/TPB Related to Hospital Acquired Infections
Intention
HCW’s plan to adhere to hand hygiene in a
variety of clinical settings for reduction of
hospital acquired infections

Attitude

Affective/cognitive evaluation of the hand
hygiene procedure itself

Beliefs about outcomes

Cognitive evaluation of the consequences of
poor hand hygiene including transmission of
the bacteria and professional behavior

Subjective norm

Overall evaluation of the extent to which
important people in the lives of HCWs are
thought to support or endorse hand hygiene
compliance as recommended
Beliefs about expectations that specific other
people hold for the HCW’s person hand
hygiene compliance

Normative beliefs

Perceived control

Overall evaluation of the degree to which a
HCW believes that hand hygiene compliance
can be performed as recommended

Control beliefs

The extent to which a HCW believes that he or
she possesses or has access to resources
required to adhere to hand hygiene compliance
in a variety of clinical settings

Figure 2. Constructs of the TRA/TPB
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Figure 3.
TRA/TPB & Hand Washing Compliance for Reduction of HA-MRSA
Infections
Attitude
Behavioral Belief: Cognitive
evaluation of the consequences
of poor hand hygiene leading to
transmission of bacteria to
patients

Subjective Norm
Normative Belief: Motivation to
comply with hand washing
because of peers/coworkers
expectations-peer pressure

Behavior
Intention

Perceived Behavioral Control
Control Belief: The extent to
which a HCW believes that he or
she possess or has access to
resources required to adhere to
hand hygiene compliance within
the hospital environment
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DEFINITION OF TERMS
Adverse Outcome- An injury that was caused by medical personnel
American Spinal Injury Association (ASIA) Impairment Scale – Level of spinal cord injury,
usually from A-D.
A=Complete: No motor or sensory function is preserved in the sacral segments S4-S5
B=Incomplete: Sensory but not motor function is preserved below the neurological level
and includes the sacral segments S4-S5
C=Incomplete: Motor function is preserved below the neurological level, and more than
half of key muscles below the neurological level have a muscle grade less than 3
D=Incomplete: Motor function is preserved below the neurological level, and at least half
of key muscles below the neurological level have a muscle grade of 3 or more
E=Normal: Motor and sensory function are normal

(www.asia-spinalinjury.org/)

Bioburden-The number of bacteria living on a surface before it is sterilized
Carrier – Organism that harbors an agent without clinical disease
Case – A patient meeting the defined hospital acquired infection definition as defined by CDC,
VHA, APIC, or other national authority
Chromogenic Agar – An agar used for the isolation and identification of methicillin - resistant
Staphylococcus aureus
Colonization – Microorganisms become established in a host without causing infection/disease
Cohort - Group of patients that share the same room or floor
Eschar– A thick leathery crust often covering an underlying necrotic process
Foley Catheter – A small flexible tube inserted into the urethra to the bladder to allow for the
drainage of urine
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Fomite – An inanimate object or material that is capable of transmitting infectious organisms
from one individual to another
Hawthorne Effect – Phenomenon that produces an improvement in human behavior or
performance as a result of increased attention from superiors or colleagues; a temporary
modification of behavior
Incidence – Number of new cases of a disease a specific population has during a period of time
Infection – A condition whereby the bacterium has invaded body tissue and is multiplying and
causing manifestations of disease, such as fever
Infection Control Measures – In addition to Standard Precautions, Transmission Based
Precautions Contact Precautions for Methicillin Resistant Staphylococcus aureus or
Clostridium difficile
Invasive – Characterized by a tendency to spread, infiltrate and intrude
Methicillin – An antibiotic in the penicillin class used in the past to treat infections from
Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus (MRSA) – A gram positive bacteria that is resistant
to methicillin or oxacillin and many other antibiotics
Methicillin-Sensitive Staphylococcus aureus (MSSA) – A gram positive bacteria that is sensitive
to methicillin or oxacillin
MRSA Bundle – Consist of contact isolation, hand hygiene, universal surveillance, & culture
change within the hospital setting
Nares – The nostrils (openings) of the nose which allow inhalation and exhalation of air
Nosocomial – Originating or taking place in a hospital
Pathogen – An agent such as bacteria capable of causing disease
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Penicillinase – Producing Staphylococcus aureus – a bacterium resistant to beta-lactam
antibiotics, particularly methicillin
PICC Line – A form of intravenous access that can be used for a prolonged period of time, such
as for extended antibiotic therapy. It is inserted through a peripheral vein and advanced
until the tip of the catheter reaches the Superior Vena Cava
Polysubstance abuse – Refers to a type of substance dependence disorder in which an individual
uses at least three different classes of substances indiscriminately
Positive Deviance – Using one's own experiences to find solutions and solve problems while still
following established hospital MRSA Infection Control Policies
Pressure Ulcer – Also known as decubitus ulcers or bedsores are localized injuries to the skin
and/or underlying tissue usually over a bony prominence as a result of pressure, or
pressure in combination with shear and/or friction. This most often occurs on the sacrum,
coccyx, heels or the hips.
Prevalence – The total number of existing cases of a specified disease in a given population
during a given period of time
Staphylococcus aureus – Bacterial species which can colonize or infect a person
Slough– Dead skin tissue that may have a yellow or white appearance
Surveillance – A system of collecting, consolidating, and analyzing resident data to determine
incidence and prevalence of a disease in a facility
Transmission (MRSA) – The transfer of a disease from one person to another. The main mode of
transmission of MRSA is person to person via hands.
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ACRONYMS
APIC – Association of Practitioners of Infection Control
BSIs – Blood Stream Infections
CDC – Centers for Disease Control and Prevention
ICU – Intensive Care Unit
IOM – Institute of Medicine
IHI – Institute for Healthcare Improvement
LOS – Length of Stay
MDROs – Multidrug Resistant Organisms
MSSA – Methicillin-sensitive Staphylococcus aureus
MRSA – Methicillin resistant Staphylococcus aureus
NICU – Neonatal Intensive Care Unit
PICC Line – Peripherally Inserted Central Catheter Line
VAMC– Veterans Affairs Medical Center
VHA – Veterans Health Administration
WHO – World Health Organization
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CHAPTER 2
RESEARCH QUESTIONS
Research Questions
Question 1 - What is the burden of HA-MRSA infection in patients with a spinal cord injury?
Question 2 - Is there an association with MRSA and age, race, weight, ASIA Score, decubitus
ulcer, diabetes mellitus, anxiety/depression, Hepatitis C, polysubstance abuse, alcohol use,
paraplegia, quadriplegia, amputee, device use, MRSA colonization, length of stay and hand
hygiene compliance?
Question 3 - What evidence from this study will validate previous studies on MRSA risk factors?
Question 4 - What new information will emerge from this study?
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CHAPTER 3
METHODS AND MATERIALS
Purpose of the Study
The purpose of this case-control study was to assess risk factors contributing to HA-MRSA
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries.
The case-control study was also conducted to see if new information would be found on HAMRSA infections and validate or refute current research on the topic for patients in a dedicated
spinal cord injury unit at a Veterans Affairs Medical Center.
Design of the Study
After obtaining Institutional Review Board approval from Georgia Regents University and the
Veterans Affairs Medical Center, data were made available from the VHA Infection Control
Department and permission granted for medical chart review.
The study was a retrospective chart review (case-control) study to gain a better understanding
of trends in MRSA colonization and infection. The intent was to provide researchers and the VA
Infection Control and Epidemiology Department with a better understanding of possible risk
factors associated with the acquisition and transmission of MRSA in a dedicated spinal cord
injury unit for fiscal years 2008-2011.
Inclusion and Exclusion Criteria
Those included in this study were male inpatients in the spinal cord injury unit 18 years of
age and older. No minors were included in the study. Subject selection criteria were purely
driven by the population of inpatients. It fairly distributes the burden, risk, and benefits of the
research as it is generated by factors specific to the pathogen and the environment that are
beyond the control of the researcher.
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Patients may have diminished capacity due to advanced dementia or other advanced or endstage medical problems. This same vulnerability is why they are susceptible to hospital acquired
infections and why much care must be taken to try to prevent them. The potential benefit from
lessons learned from surveillance and epidemiology outweighs the risk of the analysis and data
gathering that will use the medical records of these patients.
Data Source
The Veterans Affair Medical Center implemented a “MRSA Bundle” consisting of universal
nasal surveillance for MRSA, contact precautions for patients who were either colonized or
infected with MRSA, hand hygiene, and a change in the institutional culture using positive
deviance. The goal of positive deviance was to foster cultural change so that HCWs would help
find solutions to solve problems and therefore infection control and prevention became the
responsibility of everyone involved in the care of patients.
The electronic medical record for this study was initially established when a patient was
admitted to the hospital and followed until the patient was discharged or the patient expired.
“The Veterans Health Administration (VHA) utilizes a sophisticated electronic health
information system called the Veterans Health Information Systems and Technology
Architecture (VISTA). This system is a comprehensive clinical and administrative repository of
all veteran health information including laboratory, radiology and pharmacy. The computerized
patient record system (CPRS) is a system that provides a user interface for information captured
in VISTA. Health care providers use the CPRS & VISTA to update patient medical history,
place clinical orders, review laboratory results, medical images and current medications.
Microbiological culture data and relevant patient information are obtained from VISTA via a
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Clinical Informatics Service in the VA, which is responsible for extracting data from VISTA into
a relational database (SQL server).” (VHA, 2007)
Collection of MRSA Nasal Swabs
Samples of nasal secretions are obtained by hospital staff with a swab from both anterior
nares of patients within 24 hours after their admission to the hospital. Swabs are also obtained
from patients who are not known to be colonized or infected with MRSA when they are
transferred or discharged from units within the VA. The VA clinical microbiology laboratory
processes the nasal swabs with the used of standard or selective chromogenic agar for the
isolation of MRSA or with polymerase chain-reaction (PCR) based tests by rapid molecular
detection for the detection of the organism. Positive results are reported to the patient’s nursing
unit and recorded in the electronic medical record.
Study Population
The study population included male adults 18 years of age and older who had a hospital
admission to the Spinal Cord Injury Unit between fiscal years 2008-2011 at a Veterans Affair
Medical Center in the southeastern U.S. No minors were included in the study. Racial/ethnic
composition did not limit enrollment. Subject selection criteria were purely driven by the
population of inpatients. It fairly distributed the burden, risk, and benefits of the research as it
was generated by factors specific to the pathogen and the environment and are beyond the
control of the researcher.
Analysis and Interpretation of the Data
Data Collection
A retrospective case-control study was conducted. Hospital acquired MRSA infections were
identified by the Infection Control Department through routine surveillance. Once the case
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definition was met a line-list of cases was made which was added to a spreadsheet with name
and SSN and kept on a protected department network drive in the Infection Control Department.
Validation of the MRSA cohort and collection of variables was performed on these cases using
the computerized patient record system (CPRS) and the Veterans Health Information Systems
and Technology Architecture (VISTA). Database managers extracted the CNVAMC controlgroup subjects from the spinal cord injury unit for years 2008-2011 using the last 4 digits of the
SSN, name and birth year. For every MRSA case, 2 controls were randomly chosen and
stratifying on birth year. This 2:1 selection was used to improve the power of the study. All data
was de-identified before analysis. We extracted the following variables for both cases and
controls: demographic information (gender, race/ethnicity, birth year), reason for visit (admitting
diagnosis), length of stay, presence of comorbidities, ASIA score, CA-MRSA on admission and
discharge, and infection source and type. All personally identifiable information was deleted
before entry into a spreadsheet for analysis of the data. A new ID was created for this purpose for
each patient that had no link to the SSN or name and transferred to a disc by the CNVAMC data
managers. Data was not stored on the hard drive of a PC and no mobile devices were used.
Collection of Hand Hygiene Data
Hand hygiene records were collected per routine surveillance by the Infection Control
Department. Hand hygiene data for HCWs is reported quarterly and kept protected on the access
limited committee or department network drive in the Infection Control and Epidemiology
Department.
Collection of hand hygiene data for HCWs in the Spinal Cord Injury Unit was observational
and used both staff and independent monitors. The data was reported quarterly to the Infection
Control Department as part of routine surveillance. A minimum of ten opportunities to wash
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hands or use alcohol-based hand rub was observed by each department/unit and reported as a
percentage for the quarter.
Coding for this variable was entered in the following way: the four quarters in the year were
coded as 1-4 respectively; each patient was assigned a percentage based on the hand hygiene
compliance for the quarter the patient was admitted.
Collection of MRSA Case Subjects
MRSA cases were identified as part of routine surveillance by the Infection Control
Department. Once the case definition of MRSA-HAI infection, CA-MRSA infection or
colonization was met as defined by the CDC & the National Health Safety Network (NHSN), a
line-list of cases was made which was kept on protected department network drives. The data
was then de-identified before entry into a spreadsheet by VA Infection Control Practitioners and
was kept protected on the access limited committee drive or department network drive. Data was
further protected by keeping electronic information password protected and access limited and
other documents locked in filing cabinets in the PI’s research office. Investigators had access to
these materials.
Data Analysis
Prior to the data analysis, time was spent in "cleaning" the data and performed in several
stages. In the first step, variables were reviewed by looking at variances and frequencies,
outliers, coding errors, missing data, typing errors and subsequently checked with the medical
records. Also, the number of cases and controls were reviewed to make sure the number of cases
matched the number of controls. In the second stage, corrections were made, and the analysis
performed.
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The patient population of interest was described using appropriate univariate descriptive
statistics: frequencies and percentages for categorical variables and means, medians and range
and standard deviation for continuous variables and crude odd ratios (ORs) and 95% confidence
intervals (CIs) were calculated. All statistical analyses were done using IBM SPSS Statistics
(IBM Corp. Released 2011. IBM SPSS Statistics for Mac, Version 20.0. Armonk, NY: IBM
Corp.).
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CHAPTER 4
RESULTS
The purpose of this case-control study was to assess risk factors contributing to HA-MRSA
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries.
The case-control study was also conducted to see if new information would be found on HAMRSA infections and validate or refute current research on the topic for patients in a dedicated
spinal cord injury unit at a Veterans Affairs Medical Center.
This chapter is organized into the following sections to present study results: (1) descriptive
analysis for variables of interest, and; (2) analysis of research questions.
Descriptive Statistics for Variables of Interest
During the study period, the infection control department identified 95 cases of HA-MRSA
using standard surveillance methods and criteria for HAIs as defined by the CDC and the NHSN.
All cases were validated by the researcher using these criteria and a data collection tool was
constructed before study initiation. Culture information collected by the Infection Control
Department included the source, type and date of infection. Additional data that were
retrospectively collected were basic demographics, admitting diagnosis, presence of varying
comorbidities, ASIA score, presence of indwelling medical device, BMI, LOS, MRSA
colonization on admission and discharge, and quarterly hand hygiene compliance.
Ninety-five cases of HA-MRSA were identified and 190 uninfected control patients were
chosen using a random number generator. The mean age of the cohort on admission was 59.81
(+/- 11.77 S.D.), had a mean BMI of 26.56 (+/- 6.521 S.D.) and had a mean length of stay of
83.17 days (+/- 123 S.D.) (Table 2). Note that amputees were excluded from all BMI
calculations because of the questionable significance of the value.
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Table 2. Quantitative Variable Descriptive Statistics Overall and by Group

Cases

Control

Overall

N Valid
N Missing
Mean
Median
Std. Dev.
Minimum
Maximum

93
2
59.89
61.00
11.818
25.000
84.00

190
0
59.77
61.00
11.775
26.000
84.00

283
2
59.81
61.00
11.768
25.000
84.00

N Valid
N Missing
Mean
Median
Std. Dev.
Minimum
Maximum

76
2
25.99
26.00
5.992
15.000
46.000

168
11
26.82
27.00
6.748
15.000
53.000

244
12
26.56
26.00
6.521
15.000
53.000

N Valid
N Missing
Mean
Median
Std. Dev.
Minimum
Maximum

94
1
165.77
128.50
152.497
4.000
934.000

190
0
42.31
10.00
78.481
1.000
549.000

284
1
83.17
29.00
123.056
1.000
934.000

N Valid
N Missing
Mean
Median
Std. Dev.
Minimum
Maximum

95
0
.607579
.670000
.3832385
.0000
1.0000

189
1
.664603
.890000
.4167471
.0000
1.0000

284
1
.645528
.860000
.406028
.0000
1.0000

Age on
Admission

BMI1

LOS2

Hand Hygiene

1
2

Body Mass Index (Amputees Excluded)
Length of Stay (Days)
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Primary causes of spinal cord injury varied across cases and controls with the majority of
injuries caused by vehicular (Approx. 25.0 % for cases and controls), and motorcycle accidents
(9.5% for cases vs. 4.7% for controls), falls (24.2% for cases vs. 15.3% for controls), other types
of accidents (10.5% for cases vs. 15.3% for controls), gunshot wounds (8.4% for cases vs. 9.5%
for controls), spinal related injury (4.2% for cases vs. 13.2% for controls) and followed by other
causes (13.7% for cases vs. 9.5% for controls). The same variance was found for cases and
controls for admitting diagnosis. An admitting diagnosis for annual evaluation accounted for
49.5% of controls while an admitting diagnosis of decubitus ulcer accounted for 51.6% of the
cases. Urinary tract infection (7.4% for cases vs. 6.8% for controls) and other causes followed
with similar results for both cases and controls (Approx. 28.0%) (Tables 3 and 4).
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Table 3. Cause of Injury
Group
0 Control
1 Car Accident
2 Fall Accident
3 Motorcycle Accident

Reason for
Injury

4 Other Accident
5 Gun Shot Wound
6 Spinal Related
7 Other
8 Unknown

Total

Count

Total

1 Case

53

24

77

27.9%

25.3%

27.0%

29

23

52

15.3%

24.2%

18.2%

9

9

18

4.7%

9.5%

6.3%

29

10

39

15.3%

10.5%

13.7%

18

8

26

9.5%

8.4%

9.1%

25

4

29

13.2%

4.2%

10.2%

18

13

31

9.5%

13.7%

10.9%

9

4

13

% within Group
Count

4.7%
190

4.2%
95

4.6%
285

% within Group

100.0%

100.0%

100.0%

% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
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Table 4. Admitting Diagnosis by Group
Group
0 Control
1 Annual Evaluation
2 Ulcer
Admit Dx
3 UTI
4 Other
Total

Count

Total
1 Case

94

12

106

49.5%

12.6%

37.2%

24

49

73

12.6%

51.6%

25.6%

13

7

20

6.8%

7.4%

7.0%

59

27

86

% within Group
Count

31.1%
190

28.4%
95

30.2%
285

% within Group

100.0%

100.0%

100.0%

% within Group
Count
% within Group
Count
% within Group
Count

As displayed in Table 5, cases (61.6%) were more likely than controls (39.2%) to have an
ASIA score of A (complete impairment). Cases (80%) were more likely than controls (36%) to
have a pressure ulcer on admission (Table 6). Cases (56.7%) were more likely than controls
(30.2%) to have a positive nasal culture for MRSA on admission (Table 7). Cases (59.6%) were
more likely than controls (32%) to have a positive nasal culture for MRSA on discharge (Table
8).
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Table 5. ASIA Score by Group
Group
0 Control
Count
0D

% within Group

ASIA Score
2B

% within Group

11

71

36.1%

12.8%

28.2
%

30

16

46

18.1%

18.6%

18.3
%

11

6

17

Count
% within Group

6.6%

Count
3A

% within Group

% within Group

7.0% 6.7%

65

53

39.2%

61.6%

166

86

100.0%

100.0%

Count
Total

1 Case

60

Count
1C

Total

118
46.8
%
252
100.0
%

Table 6. Decubitus Ulcer by Group
Group
0 Control
0 No
Ulcer Decubitis
1 Yes
Total

Count

Total
1 Case

121

19

140

64.0%

20.0%

49.3%

68

76

144

% within Group
Count

36.0%
189

80.0%
95

50.7%
284

% within Group

100.0%

100.0%

100.0%

% within Group
Count

54

EPIDEMIOLOGY of HA-MRSA
Table 7. MRSA Colonization on Admission by Group
Group
0 Control
0 Negative
MRSA Admit
1 Positive
Total

Count

Total
1 Case

125

39

164

69.8%

43.3%

61.0%

54

51

105

% within Group
Count

30.2%
179

56.7%
90

39.0%
269

% within Group

100.0%

% within Group
Count

100.0% 100.0%

Table 8. MRSA Colonization at Discharge by Group
Group
0 Control
0 Negative
MRSA DC
1 Positive
Total

Count

Total
1 Case

121

36

157

68.0%

40.4%

58.8%

57

53

110

% within Group
Count

32.0%
178

59.6%
89

41.2%
267

% within Group

100.0%

100.0%

100.0%

% within Group
Count

Research by Eseonu, Middleton and Eseonu (2011) found in their study that a length of
hospital stay greater than 30 days was significantly associated with a MRSA infection;
therefore, the cut-points for length of hospital stay were calculated using </= 30 days and > 30
days. There were a greater proportion of cases showing longer lengths of stay with 88.3%
staying > 30 days as compared to 30.5% of controls staying > 30 days (Table 9). Medical device
use varied across groups with catheter use being 24.2% in cases and 38.9% in controls, PICC use
11.6% in cases and 1.6% in controls, and use of a catheter and PICC simultaneously 55.8% in
cases and 14.2% in controls (Table 10).
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Table 9. Length-of-Stay by Group
Group
0 Control
0 </= 30 Days
LOS
1 > 30 Days
Total

Count

Total
1 Case

132

11

143

69.5%

11.7%

50.4%

58

83

141

% within Group
Count

30.5%
190.00

88.3%
94.00

49.6%
284.00

% within Group

100.0%

100.0%

100.0%

% within Group
Count

Table 10. Device Use by Group
Group
0 Control
0 None
1 Foley
Device Use
2 PICC
3 Both
Total

Total
1 Case

Count
% within Group
Count

86
45.3%
74

8
8.4%
23

94
33.0%
97

% within Group
Count
% within Group
Count
% within Group
Count

38.9%
3
1.6%
27
14.2%
190

24.2%
11
11.6%
53
55.8%
95

34.0%
14
4.9%
80
28.1%
285

% within Group

100.0%

100.0%

100.0%

The most common sources of infection for cases were ulcer related (31.6%) and from skin
and soft tissue infections besides pressure ulcers (23.2%), 14.7% were Foley catheter related,
8.4% were blood stream infections and 22.1% were from other sites/sources (Table 11).
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Table 11. Infection Source for Cases (N=95)
Group

Total

1 Case
1 Blood
2 SST
Infection Source

3 Ulcer
4 Catheter
5 Other

Total

Count

8

8

8.4%

8.4%

22

22

23.2%

23.2%

30

30

31.6%

31.6%

14

14

14.7%

14.7%

21

21

% within Group
Count

22.1%
95

22.1%
95

% within Group

100.0%

100.0%

% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count

SST-Skin & Soft Tissue

The percentages varied in cases and controls; 67.6% of cases showed </= 89% compliance for
hand washing for HCWs and 52.4% of controls were </= 89% compliance with hand washing
for HCWs. Compliance also varied for the > 90% compliance group, case subjects showed
32.6% compliance with hand washing for HCWs and HCWs compared to 47.6% for control
subjects (Table 12).
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Table 12. Hand Hygiene Compliance by Group
Group
0 Control
0 </= 0.89
Hand Hygiene
1 >/= 0.90

Total

Count

99

% within Group

52.4%

Count

90

% within Group
Count

47.6%
189

% within Group

100.0%

Total
1 Case
64

163

67.4% 57.4%
31

121

32.6% 42.6%
95
284
100.0%

100.0
%

Analysis of Research Questions
Research Question #1
What is the burden of HA-MRSA in patients with a spinal cord injury?
A prevalence study was conducted in patients with and without spinal cord injury to
investigate the risk of hospital acquired infection by Girard, Mazoyer, Plauchu, & Rode (2006).
The prevalence of infection was higher in the spinal cord injury group than in those without
injury, 23.4% and 4.8% respectively, with most infections classified as urinary tract infection.
Urinary catheterization is very common and significantly more frequent in spinal cord injury
patients than non-spinal injury. The spinal cord injury group had a greater number of
comorbidities; however, the only independent predictor of infection was having an indwelling
urinary catheter. Other common infections found in this group included skin and soft tissue,
often related to decubitus ulcers.
In the current study, the most common source of infection for cases were from decubitus
ulcers (31.6%) and from skin and soft tissue infections (besides decubitus ulcers) (23.2%),
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14.7% were Foley catheter related, 8.4% were blood stream infections and 22.1% were from
other sites/sources (Table 13).

Table 13. Infection Source for Cases (N=95)
Group

Total

1 Case
1 Blood
2 SST
Infection Source

3 Ulcer
4 Catheter
5 Other

Total

Count

8

8

8.4%

8.4%

22

22

23.2%

23.2%

30

30

31.6%

31.6%

14

14

14.7%

14.7%

21

21

% within Group
Count

22.1%
95

22.1%
95

% within Group

100.0%

100.0%

% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count

SST-Skin & Soft Tissue

Research Question #2
Is there an association with HA-MRSA and age, race, weight, ASIA score, decubitus ulcer,
diabetes mellitus, anxiety/depression, hepatitis C, polysubstance abuse, alcohol use, paraplegia,
quadriplegia, amputee, device use, MRSA colonization, length of stay, and hand hygiene
compliance?
The unadjusted odds ratios (ORs) of MRSA-HAI were calculated for the following risk
factors: Age at Admit (median split: </= 61 vs. > 61), Race (White vs. Black), Weight Status
(Underweight or Normal: BMI < 25 vs. Overweight: BMI 25 - 29 vs. Obese: BMI > 29), ASIA
Score (D vs. C vs. B vs. A), Decubitus Ulcer (No vs. Yes), Diabetes Mellitis (No vs. Yes),
Anxiety-Depression (No vs. Yes), Hepatitis C (No vs. Yes), Poly-substance Abuse (None vs.
59

EPIDEMIOLOGY of HA-MRSA
History vs. Current), Alcohol Abuse (None vs. History vs. Current), Paraplegia (No vs. Yes),
Quadriplegia (No vs. Yes), Amputee (No vs. Yes), Device Used (None vs. Foley Only vs. PICC
Only vs. Both Foley and PICC), MRSA Colonization on Admit (Negative vs. Positive), MRSA
Colonization at Discharge (Negative vs. Positive), Length of Stay (median split: </= 30 Days vs.
> 30 Days, and Hand Hygiene (median split: > 0.90 vs. </= 0.89). It should be noted that all
calculations concerning Weight Status, as defined by BMI, excluded amputees since BMI is not
relevant for amputees.
The unadjusted ORs (Table 14) showed that the use of a Foley catheter increased the
univariate odds of HA-MRSA 3.3 fold, use of a PICC increased the odds 39.4 fold, and use of
both a Foley and PICC increased the odds 21.1 fold. A hospital length-of-stay greater than 30
days increased the univariate odds of HA-MRSA 17.1 fold. MRSA Colonization on admission
and MRSA colonization at discharge increased the univariate odds of HA-MRSA approximately
3 fold. Having a decubitis ulcer increased the univariate odds of HA-MRSA 7.1 fold. Having an
ASIA score of A (Complete Impairment) increased the univariate odds of HA-MRSA 4.4 fold.
Having an ASIA score of B or C (Incomplete Impairment) increased the univariate odds of HAMRSA approximately 2.9 fold. Having an amputation increased the univariate odds of HAMRSA 3.5 fold. Paraplegia increased the univariate odds of HA-MRSA 1.9 fold. Hand hygiene
compliance for HCWs of </= 0.89 increased the univariate odds of HA-MRSA 1.88 fold.
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Table 14. Unadjusted Odds Ratios for MRSA Hospital Acquired Infection (n = 190 Controls; n =
95 Cases)
Variable1

Categories

Age at Admit

0 </= 61
1 > 61

0 White
1 Black
0 Underweight or
Weight
Normal (BMI < 25)
Status
1 Overweight
(Amputees
(BMI 25 - 29)
Excluded)
2 Obese (BMI > 29)
0D
1C
ASIA Score
2B
3A
0 No
Decubitis
Ulcer
1 Yes
0 No
Diabetes
Mellitis
1 Yes
0 No
AnxietyDepression
1 Yes
0 No
Hepatitis C
1 Yes
0 None
Polysubstance
1 History
Abuse
2 Current
0 None
Alcohol Use 1 History
2 Current
0 No
Paraplegia
1 Yes
Race

0 Control
101 (52.3%)
89 (46.8%)

1 Case
Odds Ratio P-Value
48 (51.6%)
45 (48.4%)
1.064
0.807

107 (59.1%)
74 (40.9%)

46 (52.3%)
42 (47.7%)

65 (38.7%)

30 (39.5%)

53 (31.5%)
50 (29.8%)
60 (36.1%)
30 (18.1%)
11 (6.6%)
65 (39.2%)
121 (64.0%)
68 (36.0%)
141 (74.6%)
48 (25.4%)
132 (69.5%)
58 (30.5%)
168 (88.4%)
22 (11.6%)
148 (82.2%)
22 (12.2%)
10 (5.6%)
131 (72.4%)
28 (15.5%)
22 (12.2%)
115 (64.6%)
63 (35.4%)
61

1.320

0.288

29 (38.2%)

1.186

0.594

17 (22.4%)
11 (12.8%)
16 (18.6%)
6 (7.0%)
53 (61.6%)
19 (20.0%)
76 (80.0%)
72 (75.8%)
23 (24.2%)
74 (77.9%)
21 (22.1%)
83 (87.4%)
12 (12.6%)
74 (82.2%)
11 (12.2%)
5 (5.6%)
64 (72.7%)
11 (12.5%)
13 (14.8%)
45 (48.9%)
47 (51.1%)

0.737

0.392

2.909
2.975
4.448

0.018
0.071
< 0.001

7.118

< 0.001

0.938

0.828

0.646

0.136

1.104

0.796

1.000
1.000

1.000
1.000

0.804
1.210

0.573
0.618

1.907

0.013
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0 No
1 Yes
0 No
Amputee
1 Yes
0 None
1 Foley Only
Device Used
2 PICC Only
3 Both Foley and PICC
MRSA
0 Negative
Colonization
1 Positive
on Admit

91 (50.0%)
91 (50.0%)
179 (94.2%)
11 (5.8%)
86 (45.3%)
74 (38.9%)
3 (1.6%)
27 (14.2%)

55 (59.8%)
37 (40.2%)
78 (82.1%)
17 (17.9%)
8 (8.4%)
23 (24.2%)
11 (11.6%)
53 (55.8%)

125 (69.8%)

39 (43.3%)

54 (30.2%)

51 (56.7%)

MRSA
0 Negative
Colonization
at Discharge 1 Positive
0 </= 30 Days
Length of
Stay
1 > 30 Days
0 >/= 0.90
Hand
Hygiene
1 </= 0.89

121 (68.0%)

36 (40.4%)

57 (32.0%)

53 (59.6%)

132 (69.5%)
58 (30.5%)
90 (47.6%)
99 (52.4%)

11 (11.7%)
83 (88.3%)
31 (32.6%)
64 (67.6%)

Quadriplegia

1

0.673

0.126

3.547

0.002

3.341
39.417
21.102

< 0.001
< 0.001
< 0.001

3.027

< 0.001

3.125

< 0.001

17.172

< 0.001

1.88

0.017

Note: The reference category for each variable is the first-listed category for that variable.
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Research Question #3
What evidence from this study will validate previous studies on HA-MRSA risk factors?
Assessment of risk factors for HA-MRSA for spinal cord injury patients in this study found
that colonization, device use, paralysis, ASIA score, amputation, decubitus ulcer, length of
hospital stay and hand hygiene compliance were each associated with acquiring a HA-MRSA
infection. These risk factors are similar to those described in previous studies in other hospital
populations besides those in a spinal cord injury unit.
In addition to confirming the risk factors, this study also confirms that current efforts targeting
the reduction of MRSA in the SCIU at the VAMC are necessary due to the associated risk
factors; in particular, colonization, the number of patients admitted with decubitus ulcers and
device use. The study also affirms current assumptions about this population having special
medical needs and being at high risk for MRSA disease.
Lastly, the analysis of the data also confirms the long standing assertion that hand hygiene is
correlated with infection and transmission of MRSA.
Research Question #4
What new information on MRSA will emerge from this study?
The current study was able to provide a descriptive analysis to this hospital for patients within
a dedicated spinal cord injury unit, address specific risk factors associated with HA-MRSA and
the burden of infection. This has not been done before at this hospital for this particular
population and providing baseline characteristics to the hospital is important when making
decisions on designing and implementing an effective infection control program. The
information from this research can be used as an educational tool for patients and family and can
provide teaching points regarding contact precautions, colonization, and the importance for hand
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washing compliance. This study affirms that current efforts targeting the reduction of MRSA in
the SCIU at the VAMC, such as the MRSA bundle, are readily needed due to the associated risk
factors and characteristics of the population admitted to the spinal cord injury unit.
Due to limited information on this patient population, understanding risk factors and the
burden of MRSA in the past were generalized from data on patients in the acute care setting or
the ICU. Quality improvement processes should not always be a "one size fits all" approach and
patient populations, the organisms and site of infection are often unique to the hospital and its
environment and community. The current study found 80% of the case subjects were admitted
with decubitus ulcers, and this was the most common source of HA-MRSA infection. Some
studies have shown catheter associated urinary tract infections as the primary source of infection
in spinal cord injury patients due to the increased use of Foley catheters; however, catheter
associated infections were next to last as a source of infection in the current study.
The current study found that risk factors associated with HA-MRSA are similar to patients in
hospital populations that have been previously studied; however, univariate statistics from the
study provided a rich description of the population which will give infection control a better
understanding of their patient population being admitted. This information will aid in
strengthening the design of the infection control program currently in place or allow for the
tailoring of a needed intervention to the specific needs of the patients in the spinal cord injury
unit.
Additionally, the study also provided the basis for future analysis and to further contribute to
the knowledge base by identifying the need to study interactions/effect modifiers within the
potential risk factors previously described (e.g., age, race or device use).
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CHAPTER 5
SUMMARY, DISCUSSION, AND CONCLUSION
Summary
The purpose of this case-control study was to gain a better understanding of the burden of
HA-MRSA and to assess risk factors associated with the acquisition and transmission of HAMRSA in a dedicated spinal cord injury unit (SCIU) at a Veterans Affairs Medical Center. The
case-control study was also conducted to see if new information would emerge on HA-MRSA
infections and validate current research.
Research Question #1: What is the burden of HA-MRSA in patients with a spinal cord injury?
Patients with spinal cord injuries or disorders due to trauma, spinal stenosis, vertebral
osteomyelitis, and other causes often have a neurogenic bowel and bladder, decubitus ulcers,
frequent hospitalizations, as well as having experienced numerous surgeries. Decubitus ulcers
(pressure ulcers) often do not resolve readily and may become chronic wounds requiring
frequent dressing changes. Also, patients with a neurogenic bowel and bladder often require
digital stimulation of the bowel and urinary catheterization (Evans et al., 2012). Each of these
practices requires frequent contact with contaminated body fluids by HCWs and may lead to the
development of a HAI.
During fiscal years 2008-2011, 95 cases of MRSA were identified by the Infection Control
and Epidemiology department at the VAMC with the average age of the cohort on admission
being 59.81 years, and with a greater proportion of males vs. females. The cohort was
predominately white (52.3% cases vs. 59.1% controls).
Case infections were identified through the application of the CDC/NHSN surveillance
definitions by specific definition. Infections were divided into the following categories: (1)
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blood; (2) skin and soft tissue (SST) (cellulitis, soft tissue/wound infection); (3) skin and soft
tissue (decubitus ulcer); (4) catheter associated urinary tract infection, and; (5) other causes of
infection.
Case-control analysis of the data showed that having a decubitus ulcer upon admission
increased the univariate odds of HA-MRSA 7.1 fold (p < 0.001). Patients with decubitus ulcers
upon admission comprised 80% of the case subjects and of the 95 cases identified with HAMRSA, 31.6% subsequently acquired an infection from a decubitus ulcer site. Decubitus ulcers
were located in areas such as the sacral, ischial, trochanter, femur, and hip areas. Skin and soft
tissue infections were the second most prevalent infection comprising 23.2% of the case subjects.
Skin and soft tissue infections, causing cellulitis, were cultured from areas such as the shoulder,
inguinal region, abdomen, ankle, leg, and arm. Of the 95 MRSA cases identified, 24.2% had
indwelling Foley catheters increasing the likelihood of a HA-MRSA infection by 3.341 fold; and
subsequently, almost 15% of those patients developed a catheter associated urinary tract
infection with MRSA. Other sources such as bone-joint infection, deep tissue, lower respiratory
and ventilator associated infections, and epidural abscess accounted for 22.1% of the HA-MRSA
infections. These types of infections were collapsed into one category due to sparse numbers of
each of these in the cases. And, lastly, blood stream infections accounted for 8.4% of the HAMRSA infections and were defined as either a lab confirmed blood stream infection or associated
with a central line. In this study, a patient with a central line or PICC had a 39.42-fold increase
for a HA-MRSA infection.
Research Question #2: Is there an association with HA-MRSA and age, race, weight, ASIA
score, decubitus ulcer, diabetes mellitus, anxiety/depression, hepatitis C, polysubstance abuse,
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alcohol use, paraplegia, quadriplegia, amputee, device use, MRSA colonization, length of stay,
and hand hygiene compliance?
The average age of the cohort on admission was 59.81 years with no significant difference
occurring between cases and controls. The cohort was predominately white (52.3% cases vs.
59.1% controls), had a mean length of stay of 83.2 days and a mean hand-hygiene compliance of
65% for HCWs. The majority of the case subjects had an admitting diagnosis of decubitus ulcer
(51.6%) with the majority of controls having an admitting diagnosis of annual evaluation
(49.5%). Decubitus ulcer was the most common infection identified in the case subjects
comprising 51.6% of the group, other skin and soft tissue infections (not including decubitus
ulcers) accounted for 23.2% of the infections, Foley catheter followed with 14.7%, blood stream
infections 8.4%, and other causes of infection were 22.1%.
Case-control analysis of the data showed that having a decubitus ulcer upon admission
increased the univariate odds of HA-MRSA 7.1 fold (p < 0.001). Patients with decubitus ulcers
comprised 80% of the case subjects, and 36% of the control subjects. A hospital length-of-stay
greater than 30 days increased the univariate odds of HA-MRSA 17.1 fold (p < 0.001). Cases
showed a greater percentage at 88.3% vs. 30.5% in control subjects. The unadjusted odds ratio
showed that the use of a Foley catheter increased the univariate odds of HA-MRSA 3.3 fold (p <
0.001), use of a PICC line increased the odds 39.4 fold, (p < 0.001) and use of both a Foley
catheter and PICC line increased the odds 21.1 fold (p < 0.001). Case subjects showed a Foley
catheter use of 24.2% vs. 38.9% in control subjects, PICC line use was 11.6% in cases vs. 1.6%
in controls, and use of a Foley catheter and PICC line together comprised 55.8% of case subjects
and 14.2% of control subjects.
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An ASIA score of A (complete impairment) increased the univariate odds of HA-MRSA 4.4
fold and having an ASIA score of B or C (incomplete impairment) increased the univariate odds
approximately 2.9 fold. An ASIA score of A accounted for 61.6% of case subjects and an ASIA
score of B or C accounted for approximately 6.6% and 18.0% respectively.
Other factors associated with a significantly increased univariate odds (p < 0.05) for HAMRSA were colonization on admission (OR: 3.0) and discharge (OR: 3.1), having an amputation
(OR: 3.5), being paraplegic (OR: 1.9), and having a HCW with a hand-hygiene compliance of
</= 0.89 (OR: 1.88).
Comorbidities can play a central role in the acquisition of a hospital acquired infection
resulting in longer hospital stays, increased cost to the patient and often debilitating effects, if not
death. Older adults are at higher risk because of the presence of multiple comorbid conditions,
functional impairment and a reduced immune response. Several comorbidities included in the
study but showing no significance for increased odds of HA-MRSA included anxiety/depression,
having diabetes mellitus, hepatitis C, and poly-substance abuse.
A number of studies have shown a strong association with age and infection; however, in the
current study age was not significantly associated with infection. Kuehnert et al. (2005), using
discharge data, reported MRSA rates for septicemia, pneumonia, and other infections increased
with patient’s age with most diagnoses occurring in persons > 65 years of age. The study also
reported that the overall MRSA rate increased with patient age. Klevens et al. (2008) also found
an increase in MRSA infections among older adults aged > 65 years and in hospitals with < 200
beds. Another study, by Payman & Delorme, (2008) in a medical center reported a significant
increase in the incidence of MRSA among young patients 6-25 years of age, as well as patients
45-50, and the elderly, 86-90. In the current study, 48% of HA-MRSA infections occurring in the
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case subjects were diagnosed in patients > 61 years of age and unlike the previous studies,
slightly over half (52%) of HA-MRSA infections in the case subjects were diagnosed at </= 61
years of age. The difference in age associated infections from the general hospital population
when compared to the current population under study may be related to the multiple comorbities
associated within the spinal cord injury population.
Discussion of Major Findings
The theory informing this research, The Theory of Planned Behavior, was previously
described and provided the reader with an understanding of the behavior associated with the
HCW's intent and their adherence, or not, to hand hygiene recommendations and compliance.
Proper hand hygiene compliance has been cited in the literature as one of the most important
functions a HCW can perform to prevent the spread of infection. Due to the nature of the injury
in spinal cord patients most have had frequent hospitalizations and surgeries, many are colonized
with MRSA and have multiple decubitus ulcers, and often require use of multiple devices; each
predisposing the patient to infection. Each of these factors lead to frequent contact by HCWs and
unless adherence to hand hygiene compliance is maintained, infection may occur.
The purpose of this case-control study was to assess risk factors contributing to HA-MRSA
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries.
The case-control study was also conducted to see if new information would be found on HAMRSA infections and validate or refute current research on the topic for patients in a dedicated
spinal cord injury unit at a Veterans Affairs Medical Center.
This case-control study was also undertaken to better understand the risk factors associated
with MRSA in this population and setting due to limited information and to support needed
recommendations and efforts currently being used to reduce infections at the VAMC. Such
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efforts include: 1) PCR testing for patients admitted and transferred to the spinal cord injury unit,
2) contact isolation for patients colonized with MRSA and with an ongoing MRSA infection, 3)
increased hand washing awareness through education for HCWs and family members, and; 4)
use of gown and gloves for all having direct contact with patients colonized and infected with
MRSA. This study provides evidence to aid in the design of an effective infection control
program tailored to the specific needs of patients in the spinal cord injury unit. After analyzing a
number of variables that are well documented in the literature as risk factors in this patient
population, this study found device use, colonization with MRSA on admission, hospital lengthof-stay over 30 days, hand hygiene compliance, amputation, decubitus ulcer, ASIA score and
paraplegia as being significantly associated as risk factors for HA-MRSA.
Invasive devices pose the greatest threat to patients for serious infections. A case-control
study by Kaye, et al. (2011) found indwelling central venous catheters to be a primary cause for
HA-MRSA bloodstream infections. In the current study, of the 95 case subjects with MRSA,
11.6% had a PICC inserted upon admission increasing the odds of HA-MRSA 39.4-fold. In
contrast, the study by Kaye, et al. (2011) found the presence of a central line on admission
almost doubled the risk factor for a blood stream infection. Both studies indicate a patient is at
high risk for infection; however, spinal cord injury patients may be at a greater risk because of
being colonized with MRSA, the presence of multiple comorbidities and frequent contact by
HCWs.
The same study by Kaye, et al. (2011) and another study by Girard, Mazoyer, Plauchu, and
Rode (2006) found indwelling Foley catheter use an independent predictor for infection. The
current study found indwelling Foley catheter use increased the odds of HA-MRSA 3.3-fold. The
current research also found if both a Foley catheter and PICC line were both being used
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simultaneously, the odds increased 21.1-fold. Simultaneous use of these devices accounted for
55.8% of the MRSA case subjects vs. 14.2% of the control subjects. Due to the nature of the
injury sustained by this population of patients, many require use of an indwelling Foley catheter
as well as the use of the PICC line simultaneously for long term antibiotic therapy due to
infection or other therapeutic treatment. Although, 24.2% of cases had an indwelling Foley
catheter, and 55.8% had both a indwelling Foley and PICC line, catheter associated urinary HAMRSA were not the primary or secondary source of HA-MRSA infections.
Patients who remain in hospitals for extended lengths of time may be exposed to longer
antimicrobial use, invasive procedures, and greater contact with healthcare workers. Past studies
have suggested that each of these healthcare characteristics may increase a patient's chance to
acquire MRSA (Santos, et al., 2010; WHO, 2009). Eseonu, Middleton, & Eseonu (2011)
conducted a study in an orthopedic trauma center and found hospital length-of-stay greater than
30 days to be significantly associated with a HAI. Similarly, a hospital length-of-stay greater
than 30 days in the current study also demonstrated a significant association with a 17.2-fold
increase in the odds for acquiring HA-MRSA. In the current study, a large proportion of the case
subjects, 88.3%, remained in the hospital greater than 30 days when compared to 30.5% of the
control subjects. A prospective study by Kappel and colleagues (2008) in patients with spinal
cord injuries found a mean duration of stay of 147 days for patients with MRSA infection
compared to 63 days for MRSA negative patients. The study associated the longer
hospitalization time due to an interruption in treatment and rehabilitation because of isolation
due to the infection and also the high percentage of patients admitted with decubitus ulcers. The
study also found that MRSA positive patients had a greater frequency of ulcers on admission
when compared to MRSA negative patients. The same was true in the current study.
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The high-risk nature of the spinal cord injury patient, how sick the patient was upon
admission, when the infection occurred during the patients stay, decubitus ulcers on admission,
surgery, and the number of comorbidities present are considered possible reasons for the
differences in the length-of-stay. Estimating a true value for hospital length of stay created a
statistical challenge in this study in that MRSA infection may have increased the length of stay
and simultaneously may have increased the chance of infection (Barnett et al., 2009). Due to the
sparse sample size in the study, confounders and effect-modifiers that may have been associated
with increasing hospital length of stay were not considered in the current analysis and will
provide the basis for a future study.
Colonization and infection rates vary by setting; such as the type of health-care facility and
the population being studied (Davis, Stewart, Crouch, Florez, & Hospenthal, 2004). Recently
published studies have arrived at varying conclusions regarding colonization with MRSA and the
association with subsequent MRSA infections. Safder & Bradley (2008) found in their study that
MRSA nasal colonization increased the risk for subsequent infections four times among carriers,
particularly for patients in the ICU. Results from the current study found similar results in that
colonization with MRSA on admission would likely increase the risk for infection three fold
among carriers. Univariate statistics showed that over 56.7% of the case subjects were colonized
with MRSA on admission while only 30.2% of control subjects were colonized. By contrast,
Sarikonda, et al. (2010) and Klevens, et al. (2009) did not find colonization to be a strong
predictor for subsequent occurrence of infection. The increased colonization for case subjects
may be due to increased exposure to the hospital environment from frequent hospitalizations and
increased contact with HCWs.
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Indeed, hand hygiene is the single most effective and inexpensive way to reduce or eliminate
infections from occurring; yet, in most hospitals, the compliance rate among HCWs rarely
exceeds 50% (Gilbert, Stafford, Crosby, Fleming, & Gaynes, 2010). A study was conducted
among ICUs in hospitals that were members of the National Nosocomial Infection Surveillance
System. The study was initiated following the publication of the CDC Hand Hygiene Guide.
Forty hospitals were recruited and following the study period hand hygiene rates for HCWs were
low, resulting in a mean compliance of 56.6%. (Larson, Quiros, & Lin, 2007).
Another study, conducted by Gilbert and colleagues (2010) at a VAMC in Atlanta, GA found
similar results for hand hygiene compliance among HCWs as the previous study. The study was
conducted in the medical and surgical intensive care units using a trained observer to collect
hand hygiene compliance by the type of room (contact precaution vs. noncontact precautions).
The overall hand hygiene compliance for the surgical intensive care unit was 50.7% in contact
precaution rooms vs. 51.7% compliance in the noncontact precaution rooms. The medical
intensive care unit had similar hand hygiene compliance rates, 45.1% in contact precaution
rooms vs. 50.8% in noncontact precaution rooms. One third of patients hospitalized at the
Atlanta VA were on contact precautions, and approximately half of the patients on contact
precautions were placed under these precautions because of the implementation of the MRSA
bundle.
To match the VA's criteria, the cut point used for hand hygiene compliance was either </=.89
or >/=.90.The current analysis showed that having a hand hygiene compliance of </= 0.89 among
HCWs increased the odds for infection 1.88-fold. Hand hygiene compliance for HCWs caring
for case and control subjects varied whereas 67.6% of HCWs caring for MRSA case subjects
demonstrated </= 89% compliance and 52.4% compliance for control subjects. Compliance also
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varied for HCWs in the >/= 90% compliance group, whereas HCWs caring for MRSA case
subjects showed 32.6% compliance and 47.6% compliance in the control subjects.
Collection of hand hygiene data for HCWs in the Spinal Cord Injury Unit was observational
and used both trained staff and independent monitors. The data were reported quarterly to the
Infection Control Department as part of routine surveillance. A minimum of ten opportunities to
wash hands or use alcohol-based hand rub was observed by each department/unit and reported as
a percentage for the quarter.
Providing the unit with a staff monitor may correlate with an increased exposure of the unit to
hand hygiene education since it involves educating both the staff monitor performing the hand
hygiene observations and the manager on the unit who interprets the results. The act of
performing the hand hygiene observation may also create a Hawthorne effect, that is, artificially
improving hand hygiene temporarily.
Hand hygiene compliance is unlikely to be homogeneous across all shifts on all days of the
week, and the staff performing the observation may not be sensitive enough to indicate small
aberrations. However, for units where the staff monitor is consistently present and used, it may
best correlate with the overall culture of safety, receipt of education and interest in performance
improvement. Additionally, more accurate data about hand hygiene compliance may be provided
using the staff monitor because of reasons mentioned previously.
The other mechanism to track compliance is the independent monitor. This monitor often
provides more objective data with a higher volume of observations per period; however, this
method may also be subject to the Hawthorne effect.
Due to the Hawthorne effect, when HCWs know other people are observing them they
become more conscious and vigilant with hand washing procedures and compliance. This may
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have inflated the hand washing compliance and data reported to the Infection Control
Department in the quarterly report during the period of study.
Decubitus ulcer was significantly associated as a risk factor for HA-MRSA with a 7.18-fold
increased likelihood for infection. This was the most common infection site identified for this
population of patients with 80% of the case patients admitted to the spinal cord injury unit with a
decubitus ulcer. Yates, et al. (2009) conducted a prospective study in patients with diabetesrelated foot infections and found that wound chronicity independently predisposed patients to
MRSA infections. A prevalence study was conducted in patients with and without spinal cord
injury to investigate the risk of hospital acquired infection by Girard, Mazoyer, Plauchu, & Rode
(2006). The prevalence of infection was higher in the spinal cord injury group than in those
without injury, 23.4% and 4.8% respectively. And, unlike the population of patients in the
current study, most infections were classified as urinary tract infection. Although the prevalence
of infection was higher in the spinal cord injury group, differences may occur in the prevalence
based on type and site of infection emphasizing the importance for understanding a patient
population in individual hospital settings.
Through the identification of risk factors for MRSA, strategies may be put in place to prevent
the spread of resistant organisms with an emphasis on early detection of at-risk patients and use
of aggressive hand hygiene compliance and isolation.
Several other patient characteristics found to predispose a patient to HA-MRSA in this study
included having an amputation (OR: 3.54), having an ASIA score A (OR: 4.48) (complete
impairment) and paraplegia (OR: 1.9). These characteristics are related to a decrease in a
patient’s ability to walk, bathe, eat, and perform normal bathroom functions. These limitations
with daily functional activities require frequent patient contact by HCWs and may predispose
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patients to MRSA infection and colonization. A nested case-control study by Chen et al. (2011)
with elderly patients found that poor functional status and requiring assistance with three or more
activities an independent risk factor for MRSA surgical site infections (OR:2.73). Another study,
conducted by Kaye et al. (2011) found an association between urinary incontinence, an important
aspect of functional status in patients with spinal cord injury, and MRSA blood stream infection.
This increased risk of infection may have been related to a patient’s severity of illness, a greater
frequency of contact by HCWs, a greater likelihood of having an indwelling catheter, and
possibly related to poorer hygiene than patients without urinary incontinence. These patient
characteristics are associated with immobility and poor functional status often requiring
increased contact by HCWs and family members.
Study Strengths
One of the major strengths of this study is that it is the first attempt to describe the
population admitted to a dedicated spinal cord injury unit at this VAMC providing new
information to the hospital infection control department. Also, because of a lack of current
information in general on this population regarding the burden of MRSA and the associated risk
factors for the disease, the analysis provided current information for use at this hospital and the
data may be of value to other VAMCs for benchmarking within spinal cord units. This analysis
will be helpful to the Infection Control Department in tailoring their interventions, strengthening
existing measures, and to justify a need for increased funding to promote preventive efforts to
reduce HAIs, such as the MRSA bundle. Education can also be tailored for patients, medical
personnel, and family based on information obtained from this study such as characteristics of
the population and risk factors specifically associated with this population for HA-MRSA.
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The study also identified a need to further explore interactions and effect modifiers within the
potential risk factors such as ASIA score and decubitus ulcer and PICC line and Foley catheter.
Study Limitations
There were several limitations identified in this study primarily associated with having a
sparse sample size and missing data. Data were not available for MRSA cases for fiscal year
2008 and were not included in the study. The number of cases present in that year may have
improved the statistical power of the analysis. Data were missing for multiple quarters on hand
hygiene compliance which are observational and self-reported and may have contributed to study
bias.
Additionally, the VAMC is largely comprised of male patients. No females were included in
the study due to having only one female case identified over the period under study. Due to the
use of this VAMC population, it is not fully representative of the overall U.S. population given
that it is mostly male, over 50 years of age and at high risk for infection.
Another major limitation of the study was a sparse data set found in case subjects. This
resulted in the removal of "other" races from the study. Additionally, the sparse data set did not
allow for further analysis to be conducted for interactions/effect modifiers within the potential
risk factors. Therefore, the odds ratio for using a PICC line and a Foley catheter simultaneously
showed reduced odds for acquiring HA-MRSA when compared to using a PICC line or Foley
catheter alone.
Suggestions for Future Research
Additional research using a larger sample size for analysis of interactions and effect modifiers
within the potential risk factors may prove to show beneficial data. Also, the current study
explored healthcare associated risk factors for HA-MRSA; however, less is known about
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socioeconomic factors, as well as how living in a rural vs. an urban area may contribute to
MRSA infection and colonization. Also, comparing patients in the acute care setting to the spinal
cord injury population may provide interesting results.
Each of these ideas are important areas for further study in this population of patients and for
public health.
Implications for Public Health and the VAMC
Considered an emerging issue and a threat to public health, Healthy People 2020 created a
new goal, “...Prevent, reduce, and ultimately eliminate healthcare-associated infections (HAIs)
(US Department of Health and Human Services, 2010). Reflecting the commitment to reducing
healthcare-associated infections, two supporting objectives were created by Healthy People
2020: (HAI-1) reduce healthcare-associated infections by reducing central line associated
bloodstream infections; and (HAI-2) to reduce invasive healthcare-associated methicillinresistant Staphylococcus aureus infections by 75% nationwide (US Department of Health and
Human Services, 2010). The basis of this study was to gain a better understanding of risk factors
associated with HA-MRSA infection and address the burden of MRSA. The case-control study
was also conducted to see if new information would be found or refute current literature on HAMRSA. This information would be used to aid in the reduction and eventually the elimination of
HA-MRSA within the VAMC.
The results of this research can be used to better inform physicians, healthcare workers,
patients, and infection control practitioners about HA-MRSA infection and transmission.
Providing a descriptive analysis to this hospital for patients with a spinal cord injury, associated
risk factors for HA-MRSA and the burden of infection is important when designing and
implementing an effective infection control program.
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The VAMC had appreciated the preponderance of MRSA infections in decubitus ulcers, and
had implemented a screening program on admission to identify wounds already infected or
colonized with MRSA on admission in 2012. From the current research, the VAMC had not
appreciated the quantity of HA-MRSA for skin and soft tissue (SSTIs) infections. The VAMC
will take a closer look at what these SSTIs are and identify if there are ways to intervene. For
example, if they are surgical site infections, perhaps bolstering the pre-operative regimen to be
more efficient against MRSA will help to decrease these types of infections. If the infections are
associated with central line sites, perhaps line placement and maintenance will be reviewed.
Also, if the skin and soft tissue infections are related to boils or furuncles and in those attending
the physical therapy gym, the equipment may need more thorough cleaning.
Device use and length of stay have often been associated with increased infection rates;
however, it is interesting that the ASIA score was also associated with an increased risk for HAMRSA. Perhaps the cohorting methodology, which already gives preference to neutropenic or
immunocompromised patients for private rooms should consider the ASIA score as well to
reduce the exposure of these patients to other patients with MRSA.
Also, due to the number of HA-MRSA infections in this population, the VAMC will look to
focus interventions back on patients with decubiti and not as much on those with Foley catheters,
although important. A multivariate analysis would also be informative for a future study by
exploring potential confounders within the potential risk factors.
The evidence based information from this research can also be used as an educational tool for
patients and family and can provide teaching points regarding contact precautions, colonization,
and the importance for hand washing compliance. The VAMC certainly recognizes the need to
change the culture to increase the self-efficacy of the patients and the staff to believe they can
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achieve hand hygiene compliance. And although awkward, the VAMC encourage their patients
to remind staff to wash their hands and will continue to do so. In the future, and as nursing
competencies become more integrated into their evaluation system, it is hopeful that hand
hygiene becomes a competency that their managers evaluate them on. There is currently no
administrative oversight for hand hygiene compliance and if the individual nurse managers
address it, it is of their own volition. Once consistent hand hygiene becomes the subjective norm
and there is peer pressure, managerial pressure, and patient advocacy pressure to be consistent in
the discipline of hand hygiene, then the hand hygiene results should improve. The current
method for achieving cultural change is through education. This research will allow the VAMC
to educate staff and patients using their own data, rather than national studies to drive the
importance of their hand hygiene compliance.
The results found in this study also support the importance of the prevention strategies
currently being used at the VAMC in this population and already proven effective in acute care
or long term care. It supports the need for adhering to guidelines for each of the components of
the MRSA bundle because of such risk factors as colonization and decubitus ulcers, both
associated with HA-MRSA in this at-risk population.
Adhering to guidelines can be expensive and time consuming for healthcare workers.
Information from this study may also provide needed justification for allocation of resources and
funding to continue, strengthen, or add prevention strategies and improve quality processes as
mentioned previously.
Following these guidelines and tailoring prevention strategies based on data relative to the
spinal cord injury population allow this hospital to reflect their commitment towards the
reduction of HA-MRSA infections and can lead to a reduction in hospital and patient costs, a
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reduction in readmission rates, morbidity and mortality. Each is an important aspect in public
health.
Conclusion
The purpose of this case-control study was to assess risk factors contributing to HA-MRSA
and gain a better understanding of the burden of HA-MRSA in patients with spinal cord injuries.
The case-control study was also conducted to see if new information would be found on HAMRSA infections and validate or refute current research on the topic for patients in a dedicated
spinal cord injury unit at a Veterans Affairs Medical Center.
In 2007 the VAMC implemented a MRSA bundle consisting of universal nasal swabbing for
colonization of MRSA, contact precautions for all colonized patients with MRSA, increased
hand hygiene washing to include education and monitors, and a change in institutional culture in
that infection control became the responsibility of everyone who had contact with patients.
The success for reduction in HA-MRSA infections and transmission relies heavily on HCWs
following proper hand washing guidelines recommended by the CDC with each of the
components of the prevention "bundle" working synergistically. Evidence suggests that
interventions that are theory driven are more effective than those without a theoretical
background (Glanz & Bishop, 2010). The theory informing this research, the TRA/TPB, helped
explain the behavior and relationship between the HCWs intent and their adherence to hand
hygiene recommendations, in particular, the HCWs perceived control. To achieve greater hand
washing compliance the VAMC hopes to change the culture in the hospital and promote selfefficacy for staff. This will be achieved through education and use of the data from this research
to drive home the importance of their hand hygiene compliance.
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Infection control strategies should be tailored to a specific population as infection prevention
and quality improvement processes should not be a "one size fits all" approach. The current
study was able to provide a descriptive analysis to this hospital for patients within a dedicated
spinal cord injury unit, address specific risk factors associated with HA-MRSA, and address the
burden of HA-MRSA. This study confirms that current efforts targeting the reduction of MRSA
in the SCIU at the VAMC are justified in their use because of such risk factors as colonization
and the number of patients with decubitus ulcers on admissions. The study also affirms current
assumptions about this population being at risk for MRSA disease. And, although not
generalizable in most hospital settings, this study may be of value to other VA hospitals with
spinal cord injury units and rehabilitation settings.
Improving the quality of patient care through surveillance and prevention activities is a
valuable asset provided by infection control programs. Therefore, understanding the patient
population in the hospital setting is valuable in providing information which can help strengthen
the overall program. The current research will help the VAMC justify aggressive infection
control strategies, such as hand washing, cohorting of patients based on their ASIA score, and
adjusting the focus of interventions on patients with decubiti and not as much on those with
Foley catheters.
Over the last ten years a greater emphasis has been placed on reducing such adverse events as
HAIs caused by MRSA. Proposed guidelines, such as the MRSA bundle can aid infection control
programs in reducing infection and transmission by MRSA, deaths, and the cost related to each
of these. The current research will allow the VAMC to educate staff using their own data, not
national studies to drive home the importance of their hand hygiene. The data from this study
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will also provide information to help refocus interventions in other areas. Future research efforts
may focus studying other modifiable risk factors that predict HA-MRSA infection.
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APPENDICES
A. Protocol: Epidemiology of Hospital Acquired Methicillin-Resistant Staphylococcus
aureus in a Veterans Affairs Medical Center Spinal Cord Injury Unit: Fiscal Years 20082011
Chart Reviewer: Rebecca B. Stone
Date of Review: _________________
Data Capture Form
Patient ID

Case

Control #1

Birth Year
Race
Gender
Ethnicity
Height
Weight
BMI (Calculated)
Antibiotics: Y/N (If yes,
list)
Wound Consult: Y/N
Infection Source/Type

CA-MRSA on Admission:
Y/N
CA-MRSA on Discharge:
Y/N
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Control #2
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Device Use: (If yes,
type.e.g. central line, etc.)

Cause of Injury:
ASIA Score
Admission Date
Area of Service
Admission Diagnosis
Cause of death/underlying
cause of death
Discharge Date
Length of Stay
Neurogenic Bladder
Neurogenic Bowel
Sexual Dys. 2ndary
Diabetes Mellitus II
Hypertension
Chronic Neuropathic Pain
Anxiety/Depression
Annual Spinal Cord Eval.
Hepatitis
HIV
Decubitus Site/ Stage
Hemorrhoids
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AKA
Cholecystitis
Cholelithiasis
Hypotension
Spasms
Osteomyelitis
Anxiety/Depression/PTSD
Smoking History
Drug History
Alcohol History
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B. MRSA Validation Tool for Spinal Cord Injury Patients Age 18 & Older
Protocol: Epidemiology of Hospital Acquired Methicillin-Resistant Staphylococcus aureus
in a Veterans Affairs Medical Center Spinal Cord Injury Unit: Fiscal Years 2008-2011
Chart Reviewer: Rebecca B. Stone
Date of Validation of MRSA Cases: ____________________
(Adapted from CDC/NHSN Surveillance Definitions)
Infection (Body Site)
Clinical Criteria
Must meet the following criteria:
SSI- Surgical Site
Infection (superficial,
primary or secondary site)
Infection occurs w/I 30 days after operative
procedure
and
involves only skin and subcutaneous tissue of
the incision
And at least 1 of the following:
a. purulent drainage from incision
b. organisms isolated from an aseptically
obtained culture of fluid or tissue from
incision
c. at least 1 of the following signs and
symptoms of infection:
a. pain or tenderness
b. localized swelling
c. redness or heat
d. incision deliberately opened by
surgeon & is culture positive or not
cultured (culture negative finding does
not meet this criterion)
e. diagnosis of infection by surgeon or
attending physician
Must meet the following criteria:
SSI- (deep incisionalprimary or secondary site)
Infection occurs w/I 30 days after operative
procedure if no implant is left in place or w/I
1 yr. if implant is in place and the infection
appears to be related to the operation
and
involves deep soft tissue of the incision
101

Yes

No

EPIDEMIOLOGY of HA-MRSA
And at least 1 of the following:
a. purulent drainage from incision but not
the organ space
b. deep incision spontaneously dehisces
or deliberately opened by the surgeon and
is culture positive or not cultured when
the patient has at least 1 of the following
signs and symptoms:
a. pain or tenderness
b. fever
c. abscess or evidence of infection
involving the deep incision on direct
examination/reoperation or by
histopathology or radiology exam
d. diagnosis of infection by surgeon or
attending physician
SSI- (Organ/Space)

BSI-Blood Stream
Infection(LCBILaboratory-confirmed
bloodstream)

Must meet the following criteria:
Infection occurs w/I 30 days after the
operation if no implant is left in place or w/I
1 yr. if implant is in place and the infection
appears to be related to the operation
and
infection involves any part of the body,
excluding the skin incision, fascia, or muscle
layers that is opened during the operation
and
patient has at least 1 of the following:
a. purulent drainage from a drain placed
through a stab wound into the organ/space
b. organisms isolated from an aseptically
obtained culture of fluid or tissue in the
organ/space
c. abscess or other evidence of infection
found on direct exam, during reoperation,
histopathologic or radiologic exam
d. diagnosis by surgeon or attending
physician
Must meet at least 1 of the following criteria

1. Recognized pathogen cultured from 1 or
more blood cultures
and
organism is not related to an infection at
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another site
2. At least 1 of the following signs &
symptoms:
a. fever
b. chills
c. hypotension
d. signs and symptoms and positive
culture are not related to an infection at
another site
e. common skin contaminant cultured
from 2 or more blood cultures drawn on
separate occasions
Central Line-Associated
Blood Stream Infection
(CLABSI)

BJ-Bone & Joint Infection
(osteomyelitis)

1. A laboratory-confirmed bloodstream
infection (LCBI) where central line (CL) or
umbilical catheter (UC) was in place for >2
calendar days when all elements of the LCBI
infection criterion were first present together,
with day of device placement being Day 1,
AND
2. A CL or UC was in place on the date of
event or the day before. If the patient is
admitted or transferred into a facility with a
central line in place (e.g., tunneled or implanted
central line), day of first access is considered
Day1.
Comments:
1. Neither the insertion site nor the type of
device may be used to determine if a line
qualifies as a central line. The device must
terminate in one of the great vessels or in or
near the heart and be used for one of the
purposes outlined above, to qualify as a central
line.
2. An introducer is considered an intravascular
catheter, and depending on the location of its
tip and use, may be a central line.
3. Pacemaker wires and other nonlumened
devices inserted into central blood vessels or
the heart are not considered central lines.
≥ 1 of the following criteria:

1. Organism cultured from bone
2. Evidence of osteomyelitis on direct exam
of bone during a surgical operation or
histological exam
3. ≥2 of the following signs and symptoms
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BJ- (Joint or Bursa)

Disc Space Infection

with
no other recognized cause:
a. fever (>38º C)
b. localized swelling
c. tenderness
d. heat
e. drainage at suspected site
And at least 1 of the following:
a. organism cultured from blood
b. radiographic evidence of infection
≥ 1 of the following criteria:
1. Organism cultured from joint fluid or
synovial biopsy
2. Evidence of joint or bursa infection seen
during a surgical operation or histological
exam
3. ≥2 of the following
a. joint effusion
b. swelling
c. tenderness
d. heat
e. evidence of effusion
f. limitation of motion
And at least 1 of the following:
a. organisms and WBCs seen on Gram's
stain of joint fluid
b. positive antigen test on blood, urine, or
joint fluid
c. cellular profile and chemistries of joint
fluid consistent w/infection and not
rheumatologic disorder
d. radiographic evidence of infection
Must meet at least 1 of the following criteria:
1. Patient has organisms cultured from
vertebral disc space obtained during a
surgical procedure or aspiration
2. Evidence of disc infection during a surgical
operation or histopathological exam
3. Signs and symptoms:
a. fever
b. pain at the disc space
and
c. radiographic evidence of infection
4. Signs and symptoms:
a. fever
b. pain at the involved disc space
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CNS-Central Nervous
System (intracranial
infection-brain abscess,
sub or epidural infection,
encephalitis)

At least 1 of the following must be met:

1. Patient has organisms cultured from brain
tissue or dura.
2. Patient has an abscess or evidence of
intracranial infection seen during a
surgical operation or histopathologic
examination.
3. Patient has at least 2 of the following
signs or symptoms with no other
recognized cause:
a. headache
b. dizziness
c. fever
d. localizing neurologic signs
e. changing level of consciousness, or
confusion
and at least 1 of the following:
a. organisms seen on microscopic
examination of brain or abscess tissue
obtained by needle aspiration or by biopsy
during a surgical operation or autopsy
b. positive antigen test on blood or urine
c. radiographic evidence of infection
and
if diagnosis is made antemortem, physician
institutes appropriate antimicrobial therapy.
CNS-(meningitis)

At least 1 of the following must be met:
1. organism cultured from CSF
2. At least1 following S&S:
a. fever (>38 ºC)
b. headache
c. stiff neck
d. meningeal signs
e. cranial nerve signs
f. irritability
AND ≥1 of the following:
a. increased white cells, elevated protein,
and/or decrease glucose in CSF
b. organism seen on Gram's stain of CSF
c. organism cultured from blood
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AND if diagnosis is antemortem,
physician institutes antimicrobial therapy
CNS - (spinal abscess w/o
meningitis

CVS-Cardiovascular
System Infection(arterial
or venous)

Abscess of the spinal epidural or subdural
space w/o involvement of the CSF or
adjacent bone
1. Organism cultured from abscess in the
spinal
epidural or subdural space
2. Abscess in spinal epidural or subdural
space
seen during surgery or histo exam
3. ≥1 following signs and symptoms
a. fever (38 ºC)
b. back pain
c. focal tenderness
d. radiculitis
e. paraparesis
f. paraplegia
AND ≥1 of the following:
a. organism cultured from blood
b. radiographic evidence of spinal abscess
AND if diagnosis is antemortem,
Physician institutes antimicrobial therapy
At least 1 of the following must be met:

1. Organism cultured from arteries or veins
removed during surgical operation and, blood
culture not done or no organism cultured
from blood
2. Evidence of arterial or venous infection
seen during a surgical operation on
histological exam
3. ≥1 of following S&S
a. fever (>38 deg C)
b. pain
c. erythema
d. heat at involved vascular site
and more than 15 colonies cultured from
intravascular cannula tip and BC not done or
no organisms cultured from blood
4. Purulent drainage at involved vascular site
5. ≥1 of the following S&S:
a. fever (>38 deg C)
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CVS - (endocarditis, valve
disease, due to a device,
implant or graft)

CVS (myocarditis/pericarditis)

b. hypothermia (<37 deg C)
c. apnea
d. bradycardia
e. lethargy
f. pain
g. erythema
h. heat at vascular site
and more than 15 colonies cultured from
intravascular cannula tip and BC not done
or no organisms cultured from blood
and more than 15 colonies cultured from
intravascular cannula tip and BC not done
or no organisms cultured from blood
At least 1 of the following must be met:

1. organism cultured from valve or vegetation
2. ≥2 of the following S&S:
a. fever (>38 ºC)
b. new or changing murmur
c. embolic phenomena
d. skin manifestations (for example:
petechiae, splinter hemorrhages, painful
subcutaneous nodules)
e. CHF
f. cardiac conduction abnormality
and ≥1 of the following:
a. organism cultured from ≥2 blood
cultures
b. organism seen on Gram's stain of valve
when culture is negative or not done
c. valvular vegetation seen during a sx
procedure or autopsy
d. evidence of new vegetation seen on
echo
and ≥1 of the following:
if diagnosis is made antemortem, or
physician institutes appropriate
antimicrobial treatment
At least 1 of the following must be met:
1. Organism cultured from pericardial tissue
or fluid
2. ≥2 of the following S&S:
a. fever
b. chest pain
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c. paradoxical pulses
d. increased heart size
and at least 1 of the following:
a. abnormal EKG consistent with
myocarditis or pericarditis
b. evidence of myocarditis or pericarditis
on histo exam
c. pericardial effusion

CVS- (mediastinitis)

At least 1 of the following must be met:
1. organisms isolated by culture during
surgical procedure or needle aspiration
2. evidence of infection seen during operation
or histopathological examination
3. ≥1 of the following S&S:
a. fever
b. chest pain
c. sterna instability
and at least 1 of the following:
a. purulent discharge
b. positive culture from blood or discharge
from mediastinal area
c. mediastinal widening on x-ray

EENT- Eye, Ear, Nose,
Throat, or Mouth
Infection

At least 1 of the following must be met:

EENT - (ear mastoid)

1. pathogens cultured from purulent exudates
2. pain or redness of conjunctiva
and at least 1 of the following:
a. WBC’s and organisms seen on Gram
stain
b. purulent discharge
3. Infection of eye other than conjunctivitis:
a. physician diagnosis of eye infection
b. organism cultured from blood
At least 1 of the following must be met:
Otits externa:
1. pathogen isolated from purulent drainage
from ear canal
2. and ≥1 of the following S&S:
a. fever
b. pain
c. redness
d. drainage from ear canal
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and
a. organisms seen on gram stain from
drainage
Otitis media:
1. pathogen isolated from fluid from middle
ear
2. and ≥2 of the following S&S:
a. fever
b. pain
c. inflammation
d. retraction or decreased mobility of
eardrum
e. fluid behind eardrum
Otitis interna:
1. pathogen isolated from inner ear
2. physician diagnosis
Mastoiditis:
1. pathogen isolated from purulent drainage
of mastoid
2. and ≥2 of the following S&S:
a. fever
b. pain
c. tenderness
d. erythema
e. headache
f. facial paralysis
and at least 1 of the following
a. organism seen on gram stain
EENT - (oral cavitymouth, tongue, gums)

At least 1 of the following must be met:
1. pathogen isolated from tissues in oral
cavity
2. abscess or evidence or oral cavity infection
on examination
3. and ≥1 of the following S&S:
a. abscess
b. ulceration
and at least 1 of the following
a. organisms seen on gram stain
b. physician diagnosis and treatment

EENT- (Sinusitis)

At least 1 of the following must be met:
1. organisms isolated by culture from
purulent drainage
2. at least 1 of the following S&S:
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GI-Gastrointestinal
Infections (gastroenteritis)

IAB – Intraabdominal
Infection (gallbladder, bile
ducts, liver, spleen,
pancrease)

UR – Upper Respiratory
Tract ( pharyngitis,
laryngitis, epiglottitis)

a. fever
b. pain
c. tenderness over sinus
d. purulent exudates
e. nasal obstruction
and at least 1 of the following:
a. positive transillumination
b. positive radiographic exam
At least 1 of the following must be met:
1. acute onset of diarrhea with or w/o
vomiting or fever, and not likely
noninfectious cause
2. At least 2 of the following S&S:
a. nausea
b. vomiting
c. abdominal pain
d. fever
e. headache
At least 1 of the following must be met:

1. organism cultured from purulent material
from IAB space
2. Abscess or other evidence of IAB infection
3. ≥2 of the following S&S:
a. fever (>38 ºC)
b. nausea
c. vomiting
d. abdominal pain
e. jaundice
AND ≥1 following:
a. organism from drainage from surgically
placed drain
b. organism seen on Gram's stain of
drainage or tissue
c. organism cultured from blood or
radiographic evidence of infection
At least 1 of the following must be met:

1. ≥2 of the following S&S:
a. fever
b. erythema of pharynx
c. sore throat
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LRI-Lower Respiratory
Tract Infection, Other
than Pneumonia
(bronchitis, bronchiolitis,
tracheitis, w/o evidence of
pneumonia)

OREP-Reproductive
Tract Infection (other
infections of the
reproductive tract)

SST-Skin & Soft Tissue
Infection (cellulitis/soft
tissue/wound infection)

d. cough
e. hoarsenss
f. purulent throat exudates
and at least 1 of the following:
a. organisms isolated from the specific site
b. organisms isolated from blood
c. physician diagnosis of infection
2. abscess seen on direct examination
Must meet at least 1 of the following:

1. no clinical or radiographic evidence of
pneumonia
and at least 2 of the following S&S:
a. fever
b. cough
c. new or increased sputum production
d. rhonchi
e. wheezing
and at least 1 of the following:
a. positive culture obtained by deep
tracheal aspirate or bronchoscopy
Must meet at least 1 of the following:

1. organisms isolated from the affected site
2. abscess or evidence of infection
3. at least 2 of the following S&S:
a. fever
b. nausea
c. vomiting
d. pain
e. tenderness
f. dysuria
and
a. organisms cultured from the blood
b. physician diagnosis
Must meet at least 1 of the following:

1. Purulent draining, pustules, vesicles, or
boils 2. ≥2 of the following with no other
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Soft Tissue (necrotizing
fascitis, infectious
gangrene, necrotizing
cellulitis, infectious
myositis, lymphadenitis,
or lymphangitis)

recognized
cause:
a. pain or tenderness
b. localized swelling
c. redness
d. heat
AND ≥1 of following:
a. organism cultured from site
b. organism cultured from blood
One of the following must be met:

1. Organism cultured from site
2. Purulent drainage at site
3. Abscess or other signs of infection
observed during surgical operation or
histological exam
4. ≥2 of the following characteristics
a. organism cultured from blood
SST-Decubitus ulcer,
including superficial and
deep infections

At least 2 of the following signs and
symptoms with no other recognized causes:
1. redness
2. tenderness
3. swelling of decubitus wound edges
And ≥1 of the following:
a. organism cultured from properly
collected fluid or tissue
b. organism cultured from blood
Purulent drainage alone is not sufficient
Evidence of decubitus ulcer. Properly
collected specimen involves needle
aspiration of fluid or biopsy of
tissue from ulcer margin.

SYS-Systemic Infection
Involves multiple organs or systems w/o an
apparent single site infection.
Urinary Tract InfectionUTI
Symptomatic Urinary
Tract Infection-SUTI

Patient must meet at least 1 of the following
criteria:
1. Patient has at least 1 of the following signs
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or symptoms with no other recognized cause:
fever (>38C), urgency, frequency, dysuria, or
suprapubic tenderness
And
Patient has a positive urine culture, greater
than 100,000 microorganisms per cc of urine
with no more than 2 species of
microorganisms.
2. Patient has at least 2 of the following signs
or symptons with no other recognized cause:
fever (>38C), urgency, frequency, dysuria, or
suprapubic tenderness
AND at least 1 of the following:
a. positive dipstick for leukocyte esterase
and/nitrate
b. pyuria (urine with >10WBC high power
field of unspun urine)
c. organisms seen on Gram’s stain of
unspun urine
d. at least 2 urine cultures with repeated
isolation of the same uropathogen (gram
negative bacteria or Staphylococcus
saprophyticus) with >20,000 colonies/ml
in non-voided specimens
e. < 100,000 colonies/ml of a single
uropathogen (gram negative or
Staphylococcus saprophyticus) in a patient
being treated with an effective
antimicrobial agent for a urinary tract
infection
f. physician diagnosis of a urinary tract
infection
g. physician institutes appropriated
therapy for a urinary tract infection
OUTI-Other Infection of
the UTI (kidney, ureter,
urethra, tissue
surrounding the retroperitoneal)

Patient has at least 1 of the following criteria:

1. Positive culture from fluid other than urine
or tissue from affected site
2. An abscess or other evidence of infection
on examination during surgical operation or
histopathologic examination
3. ≥ 2 of the following signs
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and symptons:
a. fever (>38 deg C)
b. localized pain
c. localized tenderness at the involved
site
And at least 1 of the following:
a. purulent drainage from site
b. organisms cultured from blood that are
compatible with suspected site of
infection
c. radiographic evidence of infection
d. physician diagnosis of infection of the
kidney, urethra, or tissues surrounding the
retroperitoneal or perinephric space
e. physician begins appropriate therapy
for infection of the kidney, ureter,
bladder, utethra, or tissues surrounding
the retroperitoneal or perinephric space
Asymptomatic
Bacteriuria-ASB

Patient has at least 1 of the following criteria:
1. Patient has had an indwelling urinary
catheter within 7 days before the culture
AND
Patient has a positive urine culture, that is,
>100,000 organisms per cc of urine with no
more than 2 species of organisms
AND
Patient has no fever (>38C), urgency,
frequency, dysuria, or suprapubic tenderness.
2. Patient has not had an indwelling urinary
catheter within 7 days before the first positive
culture
AND
Patient has had at least 2 positive urine
cultures, that is, >100,000 organisms per cc
of urine with repeated isolation of the same
microorganism and no more than 2 species of
microorganisms
AND
Patient has no fever (>38C), urgency,
frequency, dysuria, or suprapubic tenderness.
Comments: A positive culture of a urinary
catheter tip is not an acceptable laboratory
test to diagnose a urinary tract infection.
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C. IRB Approval Letter

Date:

10/18/2012

HAC File #:

Pro00000773 , Stone Epidemiology of Hospital Acquired Methicillin-Resistant
Staphylococcus aureus in a Veterans Affairs Medical Center Spinal Cord Injury
Unit: Fiscal Years 2008-2011

Protocol Title

Epidemiology of Hospital Acquired Methicillin-Resistant Staphylococcus
aureus in a Veterans Affairs Medical Center Spinal Cord Injury Unit: Fiscal
Years 2008-2011

PI Name

Rebecca Stone

Approval
Date

10/16/2012

Expiration
Date

10/15/2013

The Human Assurance Committee (HAC) chairperson or designee reviewed and approved the
referenced study and enclosed document(s) by the expedited procedure in accordance with the
Department of Health and Human Services (DHHS) policy and the Institutional Assurance on
file with the DHHS under the following criteria:
(5) Research involving materials (data, documents, records, or specimens) that have been
collected, or will be collected solely for nonresearch purposes (such as medical treatment or
diagnosis). (Note: Some research in this category may be exempt from the HHS regulations for
the protection of human subjects, 45 CFR 46.101(b)(4). This listing refers only to research that
is not exempt.)
Approval has been granted for waiver of consent and waiver of HIPAA Authorization in
accordance with the Department of Health and Human Services DHHS) policy, the Institutional
Assurance on file with the DHHS and the Health Insurance Portability and Accountability Act
(HIPPA) policy because:
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1. The research involves no more than minimal risks to subjects.
2. The alteration or waiver of consent will not adversely affect the privacy rights and
welfare of the individuals.
3. The research could not practicably be carried out without access to and use of the
protected health information.
4. The research could not practicably be carried out without the waiver or alteration.
5. The privacy risks to individuals whose protected health information is to be used or
disclosed are reasonable in relation to the anticipated benefits, if any, to the individuals,
and the importance of the knowledge may reasonably be expected to result from the
research.
6. There is an adequate plan to protect the identifiers from improper use and disclosure.
7. There is an adequate plan to destroy identifiers at the earliest opportunity consistent with
the conduct of the research unless there is a health or research justification for retaining
the identifiers, or such retention is required by law.
8. There are adequate written assurances that the protected health information will not be
reused or disclosed to any other entity or person except as required by law, for authorized
oversight of the research project, or for other research for which the use of disclosure of
the protected information will be permitted.
The approval includes the following supporting documents
MRSA Data Collection Form.pdf

10/16/2012

0.01

The Committee calls your attention to the following obligations as Principal Investigator of this
study. Under the terms of our approved Institutional Assurance to the Department of Health and
Human Services, you must provide the HAC with a progress report at the termination of the
study, or prior to the expiration of this approval, whichever comes first. If the study will continue
beyond the initial approval term, review by the Human Assurance Committee is required, with a
progress report constituting an important part of the review.
Failure to submit a Continuation Request by its due date will result in an automatic termination
of this study. Reinstatement will only be granted following resubmission of the study to the
HAC.
The HAC has determined that the interval of continuing review as noted by the approval and
approval expiration dates above is appropriate to the degree of risk for this protocol.
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If Veterans Affairs (VA) patients or facilities will be involved in this study, a letter of
approval from the VA Research & Development Committee must also be obtained prior to
involvement of VA patients or facilities. You must also contact the VA regarding their
disclosure reporting requirements.
Please feel free to contact our office at 706-721-3110 if you have any questions.

Warning: This is a private message for eIRB users only. If the reader of this message is not the
intended recipient you are hereby notified that any dissemination, distribution or copying of
this information is STRICTLY PROHIBITED.
Human Assurance Committee (HAC)
Georgia Health Sciences University
1120 15th St., CJ-2103
Augusta GA 30912-7621
HAC@georgiahealth.edu
Office 706-721-3110http://www.georgiahealth.edu/research/ohrp/irb/hac/index.html
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D. VAMC R&D Approval Letter
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